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Abstract
Objectives:  Globally, healthcare policy promotes supported self-management as a 
strategy for people with long-term conditions. This meta-review aimed to explore how 
people with hypertension make sense of their condition, to assess the effectiveness of 
supported self-management in hypertension, and to identify effective components of 
support. 
Methods:  From a search of eight databases (Jan 1993-Oct 2012; update June 2017) 
we included systematic syntheses of qualitative studies of patients’ experiences, and 
systematic reviews of randomised controlled trials evaluating the impact of supported 
self-management on blood pressure and medication adherence.  We used meta-
ethnography, meta-Forrest plots and narrative analysis to synthesise the data. 
Results: Six qualitative and 29 quantitative reviews provided data from 98 and 446 
unique studies, respectively. Self-management support consistently reduced systolic 
BP (by between 2 and 6mmHg), and diastolic BP (by between 1 and 5mmHg). 
Information about hypertension and treatment, home BP monitoring (HBPM) and 
feedback (including telehealth) were widely used in effective interventions.  Patients’ 
perceptions of a disease with multiple symptoms contrasted with the professional view 
of an asymptomatic condition.   HBPM, in the context of a supportive patient-
professional relationship, changed perceptions of the significance of symptoms and 
fostered confidence in ability to self-manage hypertension.  
Conclusions:  Our systematic qualitative and quantitative meta-reviews tell 
complementary stories.  Supported self-management can improve blood pressure 
control. Interventions are complex and encompass a broad range of support strategies. 
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HBPM (with or without telehealth) within the context of a supportive patient-professional 
partnership can bridge the gap between medical and lay perspectives of hypertension 
and enable effective self-management.  
 
 
Key words 
Hypertension; supported self-management; home blood pressure monitoring; 
telehealth; systematic meta-review; systematic review; meta-analysis; qualitative 
synthesis;   
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Condensed Abstract 
Our meta-review synthesised the findings of 6 qualitative (98 studies) and 29 
quantitative (446 Randomised Controlled Trials) reviews. Self-management support for 
hypertension consistently reduced blood pressure. Interventions are complex, 
encompassing support strategies such as information about hypertension/treatment, 
home BP monitoring (HBPM) and feedback (including telehealth). Patients’ perceptions 
of a disease with multiple symptoms contrasted with the professional view of an 
asymptomatic condition. HBPM, in the context of a supportive patient-professional 
relationship, increased patients’ understanding of hypertension, potentially bridging the 
gap between medical and lay perspectives of hypertension and enabling effective self-
management. 
 
Abbreviations definitions 
BP  Blood pressure 
HBPM  Home blood pressure monitoring 
LTCs   Long-term conditions  
MeSH  Medical subject headings 
PICOS Population, Intervention, Comparator, Outcome, Setting 
PRISMA   Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
PRISMS   Practical systematic Review of Self-Management Support for long-term 
conditions 
RCTs   Randomised Controlled Trials  
R-AMSTAR  Revised Assessment of Multiple Systematic Reviews  
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Introduction 
Hypertension is an important public health problem globally, with an estimated 1.56 
billion adults predicted to have the disease by 2025 [1].  As a major risk factor for renal 
failure, ischaemic heart disease, stroke, and other cardiovascular diseases[1], poorly 
controlled hypertension contributes to substantial morbidity and mortality. Ischaemic 
heart disease and stroke were leading causes of death globally in 2010 [2] and predicted 
to remain so in 2030 [3]. This represents a large, and increasing, burden of potentially 
preventable and treatable disease and one that, alongside other long-term conditions 
(LTCs), healthcare systems around the world need to address[1].  
 
One response to the mounting global challenge of managing LTCs, is the promotion of 
supported self-management[4-6], with a shift from paternalistic to partnership models of 
care[7]. Self-management has been defined as ‘..the tasks that individuals must 
undertake to live with one or more chronic conditions’ and includes having the 
‘confidence to deal with medical management, role management and emotional 
management of their conditions’[8]. Self-management support includes ‘any activities 
that support people in their self-management’[9] and a broad range of strategies have 
been used to meet the support needs of people living with LTCs[9,10].  Some strategies 
are common to all conditions (such as provision of information and professional support) 
whilst others will be specific to diverse conditions or contexts. For example, variable 
conditions such as asthma benefit from provision of ‘action plans’ to support timely self-
management of attacks[11]; whereas therapy rehabilitation and psychosocial support 
are more important for people living with the disabling but stable impact of a 
stroke[12,13]. The evidence for self-management support for hypertension, an 
asymptomatic condition in which the key objective is reducing the risk of complications 
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[1,14] is less clear, though there is increasing interest in promoting lifestyle change and 
the role of telehealth to monitor blood pressure[14].  
 
As part of a large systematic meta-review of the literature completed in 2013 on self-
management support for LTCs (PRISMS - Practical systematic Review of Self-
Management Support for long-term conditions)[15], we synthesised the evidence 
around self-management support interventions for people with hypertension; this paper 
reports an update undertaken in 2017. Meta-reviews provide broad perspectives, ideal 
for informing policy-makers, commissioners and providers of healthcare services[16]. 
We reviewed qualitative systematic reviews to explore how people with hypertension 
make sense of their condition and understand self-management strategies, and 
quantitative systematic reviews to identify which self-management support interventions 
are effective.   
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Methods 
This update followed the methods used in the PRISMS meta-review[15], which was 
based on Cochrane methodology[17].  (The study could not be registered because 
PROSPERO does not register meta-reviews) 
 
Search strategy: We used a ‘PICOS’ search strategy, with basic search terms of ‘self-
management support’ AND ‘hypertension’ AND ‘systematic review’. The full search 
protocol, search terms and MeSH terms are available in Supplementary Digital Content 
(SDC) file 1. The original PRISMS search was from January 1993 (when systematic 
review methodology was defined by the Cochrane collaboration) until October 2012; the 
update search was undertaken in June 2017.  We searched eight electronic databases: 
MEDLINE, EMBASE, CINAHL, PsychINFO, AMED, BNI, Cochrane Database of 
Systematic Reviews and Database of Abstracts of Reviews of Effects, checked the 
bibliographies of eligible reviews and undertook a forward citation search (Web of 
Science).   
 
Screening and selection criteria: Following training, title and abstract screening was 
carried out by AS or GP/EE (PRISMS review) and OS (Update). Full text screening was 
then performed by AS (PRISMS) and OS/DD (Update). At all stages of screening, a 
random 10% sample of titles were independently examined by GP/EE (PRISMS review) 
and GP/AS (Update), as a quality check. Discussion with SJCT/HP resolved 
disagreements. 
 
Population: We included studies from all healthcare settings where self-management 
support was delivered to populations with diagnosed hypertension, with no exclusions 
made for age, gender, or ethnicity. Reviews were excluded when they focussed solely 
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on secondary hypertension, children or pregnant women because we considered that 
they might not be representative of the general supported self-management of 
hypertension.  
 
Intervention: We included quantitative systematic reviews if they searched for 
interventions that met our definition of self-management support[8]. We excluded 
reviews focussing solely on mono-component interventions (such as meditation, 
relaxation, exercise), other than interventions described as providing only ‘education’ 
which we regarded as an essential component of supported self-management[15].  We 
included qualitative reviews which informed strategies to support self-management 
(including general experiences of living with hypertension and using hypertension 
services).   
 
Comparator: All comparators (typically ‘usual care’) were included; we noted details of 
the control service in our analysis. 
 
Outcomes: Our primary clinical outcome was mean difference in blood pressure 
(systolic and diastolic) and, reflecting the mechanism by which hypertension is 
controlled, adherence to medication was the key process outcome.  
 
Study design: We included quantitative systematic reviews of Randomised Controlled 
Trials (RCTs) or mixed method reviews in which the RCT data could be extracted. 
Qualitative systematic reviews were included if they provided a synthesis of qualitative 
primary studies. We excluded reviews that were unpublished, if they were not in English, 
if we were unable to extract data about people with hypertension, or if a more recent 
updated version had been published. See SDC file 1 for detailed exclusion criteria.  
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Data extraction and quality assessment: Data were extracted by AS/GP (PRISMS 
review), OJ/DD (Update) using a piloted data extraction table; 10% of the completed 
data extraction tables were checked by a second reviewer (GP/HLP for PRISMS; 
GP/AS for the update).   All numerical data in tables or figures were checked by HP 
prior to publication. 
 
We used the Revised Assessment of Multiple Systematic Reviews (R-AMSTAR) quality 
appraisal tool to assess the quality of all included systematic reviews[18].  
x For qualitative reviews, an adapted R-AMSTAR was used with high quality 
defined as those scoring of ≥ 30 (out of possible R-AMSTAR score of 40) and 
low quality if < 30. 
x For quantitative reviews, we applied a weighting system, taking into 
consideration both the quality score (high quality, defined as a score of ≥31 (out 
of possible R-AMSTAR score of 44) or low quality, a score <31) and number of 
participants (large ≥3,000 or small <3,000).   Studies were rated from 1 star 
(small, low-quality reviews) to 3 stars (large, high-quality reviews).  Small, high-
quality or large, low-quality reviews were rated 2-star.  Assessments of 
publication bias in the include reviews was noted.  
Quality assessment was undertaken by AS or GP (PRISMS) and OJ or DD (Update), 
with a random 10% checked independently by a second reviewer (HLP/GP for PRISMS; 
GP/AS for update). Disagreements were resolved by discussion and, if necessary, with 
the involvement of a third reviewer (HP/SJT/EE).  
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Data synthesis: Initially, data from the included quantitative and qualitative reviews 
were analysed and synthesised separately.  
x We employed a meta-ethnographic framework to synthesise the qualitative review 
data (GP/DD building on initial work by AS)[19]. Reciprocal translation was first used 
to examine patterns and identify metaphors arising within the included reviews. A 
lines-of-argument synthesis then interpreted the findings into a broader 
understanding to inform future development of self-management support 
interventions in a healthcare context[19].  
x For the quantitative analysis (AS/OS) we performed a narrative synthesis (overlap 
of included RCTs between reviews precludes meta-analysis), using the PRISMS 
taxonomy to categorise components of self-management support[9]. We illustrated 
the results of included meta-analyses in meta-Forrest plots. 
Synthesis of the data from the quantitative and qualitative reviews involved discussion 
amongst the multidisciplinary study team to ensure balanced interpretation. 
 
Pre-publication check 
We undertook a pre-publication check in April 2018 using the ‘efficient and effective’ 
approach of forward citation of all included reviews using Google Scholar[20]. We 
undertook focused data extraction of key outcomes (HP checked by GP) which we cite 
as corroborative data. Had we identified studies that substantially changed our 
conclusions we planned full duplicate data extraction, quality assessment and revision 
of our synthesis. 
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Results 
The screening process is illustrated in the PRISMA flow diagram (Figure 1). The 
PRISMS meta-review identified 11,098 references from which two qualitative and ten 
quantitative systematic reviews were selected.  The update search yielded 13,055 
citations from which we selected an additional four qualitative and 19 quantitative 
reviews.  
 
Review characteristics 
Summaries of included studies are in Tables 1 (qualitative) and 2 (quantitative) with 
quality scores and quantitative star ratings in column 1.  SDC file 1 has details of the R-
AMSTAR scores and tables summarising the degree of overlap between the studies 
included in the reviews. 
 
The six qualitative systematic reviews (2007 to 2017)[21-26], reported 98 unique 
primary qualitative studies, published between 1980 and 2015, and undertaken in at 
least 27 countries.  Three reviews were scored as being of high quality[23-25].  
 
The 29 quantitative systematic reviews[27-56], were published between 1998 [35]  and 
2017 [27,34,48], included 446 unique RCTs dating from 1973 to 2016, and were 
conducted in at least 12 different countries including high- middle- and low- income 
settings. Total numbers of participants in the RCTs, where reported, ranged from 382 
to more than 87,000 [36].  Fourteen reviews undertook meta-analyses of blood pressure 
data[30,31,33-36,39,41,43,47,48,51,53,55]; the remainder presented narrative 
synthesis only. The R-AMSTAR scores ranged from 18 [32] to 41 [48] with seven 
reviews allocated 3-star ratings[30,34,36,39,43,48,50]. We identified two additional 
quantitative reviews in the pre-publication check[56,57]. 
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Overview of results 
We first describe the qualitative findings which explore patients’ understanding of 
hypertension and perceptions of working together with healthcare professionals to 
manage the condition.   We then present the findings of the quantitative systematic 
reviews which assess the impact of different self-management support strategies on BP 
control and medication adherence.  Finally, we present an over-arching synthesis of the 
findings of the qualitative and quantitative meta-reviews. 
 
Synthesis of qualitative findings  
We identified two overarching metaphors (Figure 2): ‘Understanding Hypertension’ and 
‘Working Together’.  See Table 1 for a summary table of qualitative reviews and SDC 
file 2 for more detail and illustrative quotes to support these metaphors and the sub-
themes. 
 
Understanding hypertension 
People with hypertension reported a wide variety of factors contributing to their 
experience and understanding of the condition.  A range of beliefs about the definition 
and causes of hypertension, influenced by cultural factors[21,24,26], were identified, 
including that it was a ‘temporary’ condition that was not serious[21,24,26],or being two 
distinct conditions: ‘high-pertension’, resulting from intense emotions or anxiety, and 
‘high blood’, a chronic condition due to genetics and diet[21].  Stress (for example 
financial or family problems, racism and stressful life events) was commonly believed 
to cause/worsen hypertension[21,23,24,26]. Diet, such as high salt intake, was also 
recognised by many as a cause[21,23,26]. Participants frequently described a range of 
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different symptoms associated with high blood pressure, and in particular headache and 
dizziness[21,24,26].   Most clinicians believe hypertension is symptomless, and 
therefore the presence of symptoms provided a source of confusion to patients[23].  
 
How people manage their hypertension, and particularly medication adherence, was 
influenced by a range of factors.  Deliberately choosing to avoid or reduce medication 
(intentional non-adherence), rather than forgetfulness, was a theme in some 
studies[24]. For some patients, symptoms acted as a guide for the seriousness of their 
hypertension and guided their medication use; for example, they stopped treatment if 
symptoms disappeared[22-24,26]. Some were guided by stress, using medication to 
manage worry or anxiety rather than hypertension[24,26].  For others, fear of 
dependency affected the amount of medication they took[24].  A range of individual and 
social factors including; familial (lack of support, need for separate meals), and 
environmental (sense of security, local amenities, healthy food availability) were 
identified as challenges to treatment adherence[23]. Financial status[23,26], and 
logistical issues (frequency of appointments, work schedules, accessibility)[23], also 
posed challenges to self-management.  
 
Working together 
The impact of the patient-professional relationship on (self-)management of 
hypertension, and the influence of home blood pressure monitoring (HBPM) was 
highlighted.  People with hypertension valued individualised targeted treatment that took 
account of their circumstances[22].  Differences between clinicians’ and patients’ beliefs 
were potential sources of confusion and mistrust[22,23,25,26], and were related to both 
cultural and individual beliefs[21,23,26].  These included differences about perceptions 
of symptoms, disease management, and treatment expectations[22].  More adherent 
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patients tended to describe their healthcare professional as caring and listening, and 
the relationship as a partnership with joint goal setting and holding individuals 
accountable for their behaviour[26].  
 
Ambiguity about management and prognosis emerged across studies[22-24,26], with 
the importance of information clarity identified. Fear for the future was reported, 
including ability to manage physically and afford care[23]. Tailored management plans 
with more information regarding risk factors, prevention, management, and 
complications of hypertension, as well as group sessions with information about 
hypertension and diet were frequently requested[23].  
 
Self-monitoring of BP could foster a therapeutic alliance[22], specifically changing 
perceptions of the significance of symptoms and fostering a sense of self-control, 
motivation, and increased confidence in managing hypertension[22,25]. Patients 
perceived HBPM as allowing more accurate and regular monitoring than healthcare 
professionals could provide[22,25], though some perceived that clinicians were negative 
about HBPM[22,23,25].   Concern about technical skills, differences between home and 
clinic measurements, and uncertainty interpreting and acting upon measurements could 
be problematic[22,23,25], echoing the importance of clarity with treatment advice and 
information.  
 
Synthesis of quantitative findings  
The quantitative analysis summarises the impact of supported self-management on BP 
control, identifies the support components employed mapped to the PRISMS 
taxonomy[9], and the evidence of effectiveness for the commonest components 
(information, monitoring with feedback, strategies to improve adherence, support for 
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lifestyle change). See Table 2 for the summary table and SDC3 for mapping to the 
PRISMS taxonomy[13].  
 
Impact of supported self-management on BP control 
The impact of supported self-management on systolic and diastolic BP is illustrated in 
a meta-Forest plot (Figure 3).  The results of the 11 meta-analyses (five 3*; five 2*; one 
1*) that presented the results as mean differences suggest that provision of self-
management support reduces systolic BP by between 2 and 6 mmHg, and diastolic BP 
by between 1 and 5 mmHg[30,31,33-36,39,41,43,47,55]. The two outliers with 
considerably greater effect sizes (Lu 2012[39] and Xu 2014[55]) included only trials 
conducted in China where ‘usual care’ may be different to other healthcare contexts. 
Nine of the 14 reviews (one 3*; seven 2*; five 1*) using a narrative synthesis reported 
positive impact on BP in the majority of their included RCTs[32,37,40,42,4446,49,51].  
 
Components of self-management support 
SDC file 3 shows the interventions described in the systematic reviews mapped to the 
components of the PRISMS taxonomy of self-management support[9] and illustrates 
the frequency with which they are encountered in self-management support 
interventions.  Almost all components of the PRISMS taxonomy were reported in one 
or more of the hypertension self-management support interventions, most commonly 
Information about condition and/or its management (Education) (A1); Monitoring of 
condition with feedback (A5); Provision of equipment (A6); Lifestyle advice and support 
(A14); Regular clinical review (A4) and Provision of access to professional support when 
needed (A7).  The only components not featured were Training/rehearsal to 
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communicate with healthcare professionals (A9) and Training/rehearsal for everyday 
activities (A10). 
 
Effectiveness of specific components 
The effect of interventions including the commoner components is described below: 
x “Information about hypertension and its management” was a substantial component 
of self-management support in all but two interventions. The exceptions were 
reviews of dietary recommendations[47] or lifestyle interventions[33] for people with 
hypertension, but which did not specify provision of disease-specific information. 
The content and mode of delivery varied.  Although ‘education alone’ was generally 
ineffective[35,36,50], strategies including tailoring of information[34,38,48,52], 
interactive group education sessions[39,45,55], linking with HBPM[35,36], or 
behavioural strategies[50] could improve outcomes. 
x Monitoring of blood pressure with feedback was a feature of self-management 
support in 17 out of 29 reviews, though the monitoring process varied.  Home BP 
monitoring[28,31,35,36,42,46,48,50], was often mediated by 
telehealth[27,29,32,34,37,41,43,52,53], and in some reviews also included 
monitoring of medication intake, weight, physical activity and smoking[40,52]. The 
impact of monitoring on blood pressure control varied, with evidence that monitoring 
associated with feedback from healthcare professionals (including via telehealth) or 
as part of a complex intervention to promote medication adherence was more likely 
to be effective than self-monitoring as an unsupported intervention[27,31,34,42].   An 
individual patient data meta-analysis identified in the pre-publication check similarly 
showed HBPM worked best when combined with more intensive self-management 
interventions but had little or no effect on its own[56].  
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x Practical help with adherence encompassed a range of strategies (reminders, 
packaging, scheduling of appointments, regime simplification) with no one approach 
being consistently effective.  In 9 out of 14 interventions this component had no effect 
or a small effect of doubtful clinical significance[27,28,35,38,40,42,43,50,51].  
Interventions tailored to the specific needs of the target group (e.g. African American 
communities[48]) or delivered within the context of case-management[54] or 
supported by HPBP[57] may be effective.   
x Lifestyle advice and support was included in 13 reviews and was the focus of 
investigation in one review[33], which concluded that when lifestyle advice and 
support is included within a complex intervention, it can have an impact on reducing 
BP. 
 
Over-arching synthesis 
Table 3 uses the PRISMS taxonomy of self-management support[9] to map insights 
from the qualitative lines-of-argument synthesis and components of the interventions 
reported in the quantitative systematic review.   Central to these themes is the potential 
barrier of discordant beliefs between patients and their clinicians, and the need to 
address these beliefs within the context of a supportive therapeutic relationship.   A 
specific intervention, which was perceived to have influenced this relationship, is the 
introduction of HPBM[22].  Six of the effective interventions illustrated in the meta-
Forrest plot (Figure 3)[31,34-36,41,43], included HBPM (three mediated via 
telehealth)[34,41,43]. 
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Discussion 
Summary of main findings 
Our meta-review summarises the findings of six qualitative syntheses (98 unique 
qualitative studies) and 29 systematic reviews (446 unique RCTs).   Overall, there was 
consistent evidence (from 11 meta-analyses and 9 narrative reviews) that self-
management for hypertension reduces systolic and diastolic BP. Interventions targeted 
most of the 14 components of supported self-management described in the PRISMS 
taxonomy, with ‘information about hypertension and treatment’, and ‘home monitoring 
and feedback (including telehealth)’ being widely used in effective interventions.  
Strategies to improve adherence, and lifestyle interventions could be effective if 
individually tailored and delivered in the context of complex interventions. 
  
The qualitative meta-review highlighted conflicting health beliefs between people with 
hypertension, who considered stress to be an important cause of hypertension and 
attributed a range of symptoms to high blood pressure, and health professionals who 
considered hypertension to be an asymptomatic physical condition.  Strategies 
suggested to bridge this gap included identifying individual and cultural beliefs, provision 
of tailored information, and supported use of HBPM, which enables people to increase 
their understanding and awareness of their condition.  The success of these strategies 
was strongly influenced by a collaborative relationship between patient and 
professional.  
 
Strengths and limitations 
Using robust methodology, this meta-review is the first to synthesise both qualitative 
and quantitative evidence on supported self-management hypertension.  Meta-reviews 
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facilitate synthesis of a very broad literature (we included evidence from 452 studies) 
but have some inherent limitations.  Data are not extracted from the individual RCTs or 
qualitative studies, so we were reliant upon the detail and accuracy provided by the 
systematic review authors. This enables a high-level overview of the literature in the 
field (ideal for informing policy and healthcare service development) but re-synthesis of 
material already synthesised risks loss of granularity.   In addition, studies are only 
included if they have been included in a systematic review, which imposes a delay, 
though our update and pre-publication check included reviews published in 2017 and 
papers as recent as 2016.   
 
We applied our definition of self-management support to be consistent and inclusive 
across the literature[8], and included interventions that empowered the patient to take 
decisions about their management.  This explicitly included education in the context of 
interventions supporting people to cope with the medical, emotional and role challenges 
of living with hypertension.  However, in the context of hypertension, the terminology of 
‘supported self-management’ is not widely used, and we may have missed some 
papers. The reviews included studies reporting complex interventions, and limited 
descriptions may mean that we have overlooked some components relevant to the 
PRISMS taxonomy.   We did, however, include data about individual studies from the 
review tables and included all relevant details. Our training, quality check and multi-
disciplinary team approach reduced the potential subjectivity of these decisions.   Of the 
nine reviews reporting publication bias, only five considered that there may have been 
some bias[31,39,48,53,55].  
 
Reflexivity describes the fundamental concept in qualitative synthesis, that readers 
approach the data from different perspectives and will thus interpret data differently [58]. 
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We used repeated discussion within our multidisciplinary team to ensure a balanced 
interpretation 
 
Interpretation of findings in relation to previously published work 
In LTCs with a well-established evidence base for supported self-management, such as 
asthma[11,59], disease presence and severity can be monitored by the presence or 
absence of symptoms.  As an asymptomatic condition[14], hypertension has 
traditionally been managed by clinicians measuring blood pressure at intervals. This 
has limited patients to passively complying with the clinicians’ instructions.  The findings 
of our qualitative meta-review, however, challenge this medical viewpoint, as patients 
perceive symptoms which confirm (or not) the presence of high blood pressure and 
which some people described using to monitor their treatment regimes[22-24,26]. 
 
The recent Lancet Commission on hypertension identifies ‘sustained education using 
new technologies’ as a key action and calls for ‘RCTs to assess the effectiveness of 
empowering patients to take control’[1].  Our synthesis of qualitative and quantitative 
studies offers insights into these recommendations.  HBPM (with or without telehealth) 
enables patients to take measurements hitherto part of a clinical assessment potentially 
challenging the dynamics of the patient-professional relationship.  HBPM can be used 
to prove – or challenge – the diagnosis, and enhances the potential for supported self-
management.   Patients described how monitoring their blood pressure changed their 
understanding of their condition and empowered them to engage in lifestyle changes 
and self-management[22,25]. Self-monitoring and titration of medication can reduce 
blood pressure[60], and is a postulated mode of action in effective telehealth trials[61]. 
The ‘therapeutic alliance’ between patient and professional, underpinned by good 
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interpersonal communication skills, were highlighted as crucial in realising the benefits 
of HBPM. 
 
Our findings of inconsistent outcomes from interventions designed to empower lifestyle 
and medication adherence change corroborates previous research[62].   Even in a 
condition such as hypertension, where treatment is (comparatively) straightforward, our 
qualitative meta-review reveals how patient beliefs vary and influence their adherence, 
in keeping with the ‘perceptions and practicalities model’ discussed by Horne et al[63].   
The breadth of support interventions described in the PRISMS taxonomy of self-
management support – almost all of which were represented in both the quantitative 
and qualitative meta-reviews – highlights that one size does not fit all.  Complex 
interventions need to be tailored to individuals, their demographic and cultural beliefs 
as well as clinical context in keeping with the findings of the wider PRISMS meta-review 
of LTCs[15].   
 
There is a strong dose response association between blood pressure and 
cardiovascular mortality,[1] with cited benefits of ‘an approximate halving in risk for each 
10 mm Hg diastolic reduction’[64].  The magnitude of effect reported in the included 
systematic reviews suggest that supported self-management might be expected to 
reduce stroke risk by 20% and coronary heart disease risk by 10%[65]. 
 
Conclusion:  
Our novel synthesis of systematic qualitative and quantitative meta-reviews tells a 
consistent story.  Supported self-management can improve control of blood pressure 
control.  Interventions are complex and encompass a broad range of support strategies.  
HBPM (with or without telehealth) within the context of a supportive patient/professional 
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partnership helps bridge the gap between medical and lay perspectives of hypertension 
and enable effective self-management. 
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Figure 3.  Meta-Forest plots illustrating mean difference in BP
a) Systolic BP b) Diastolic BP
This meta-Forest plot illustrates the summary statistics of the included meta-analyses; overlap of included RCTs precludes further 
meta-analysis. Details of assessments of heterogeneity and publication bias, if reported by the individual systematic reviews, are 
given in SDC file 3. 
The two studies illustrated in grey included only trials conducted in China
*** Cheema 2014
**   Dickenson 2006
*** Duan 2017
**   Ebrahim 1998
*** Glynn 2010
*** Lu 2012
**   McLean 2013
*** Omboni 2013
**   Riegel 2016
**   Verbek 2011
*     Xu 2014
Figure 3- meta-Forest plots
Table 1. Summary of the included qualitative systematic reviews. 
Review;  
Number of BP studies  
R-AMSTAR  
Review aim Populations studied Key themes  
Buckley 2016 21 
8 studies (of 22 papers) 
R-AMSTAR = 29 
To identify beliefs about 
hypertension that are prevalent 
among African Americans. 
African American participants    Health beliefs concerning hypertension may differ from those of HCPs.  
HCPs should elicit and discuss the patient’s perspective.  
Interventions designed to reconcile these differences may improve adherence to prescribed 
health behaviours and patient outcomes. 
Fletcher 2016 22 
11 studies (of 12 papers) 
R-AMSTAR = 29 
To investigate motivation, barriers 
and facilitators, and how 
patients/HCPs use and 
communicate about HBPM  
Ambulatory patients with 
hypertension and their HCPs from 
primary care, outpatient clinics or the 
community. 
HBPM, in conjunction with education about hypertension improves: 
x Patients understanding, enables them to act, empowers interaction with clinicians.  
x HCPs picture of BP control, but raised concern about patients reaction to readings 
Uncertainty could be reduced by providing information about interpreting HBPM, what variation 
is acceptable, adjustment for home-clinic difference, when patients should be concerned, and 
how to act. 
Khatib 2014 23 
16 studies (of 25 papers) 
R-AMSTAR = 33 
To review the barriers reported by 
patients and HCPs that may 
impede awareness, treatment, or 
follow up of hypertension. 
Patients with, or at risk of, 
hypertension. HCPs (doctors, nurses, 
other), in primary care or hospital. 
There was a wide range of barriers facing patients and HCPs pursuing hypertension control, 
indicating the need for targeted multi-faceted interventions.  
More methodologically rigorous studies addressing known barriers (including in LMICs) are 
required in order to inform policies to improve hypertension control. 
Morton 2016 25 
8 studies (of 30 papers) 
R-AMSTAR = 34 
To understand the experiences of 
patients and HCPs using self-
management digital interventions 
for LTCs 
Adults with LTCs and HCPs involved 
in their care.  
Self-management digital interventions were perceived to:  
x Patients perceived closer contact with HCPs, and felt better cared for. Monitoring their BP 
increased self-awareness of their condition, motivated lifestyle change.  
x HCPs perceived clinical benefits, but raised concerns about the burden for them of 
monitoring patient data. 
Marshall 2012 24 
53 studies (of 59 papers) 
R-AMSTAR = 33 
To explore lay understandings and 
experiences (including in different 
cultures) about BP and medication, 
and how these affect adherence 
and BP control.  
 
People with uncomplicated 
hypertension, 16 countries (USA, UK, 
Brazil, Sweden, Ghana, Canada, 
New Zealand, Denmark, Finland, 
Iran, Israel, Netherlands, Korea, 
Spain, Tanzania Thailand) 
Common perceptions, consistent across countries and ethnic group, were:  
x BP was caused by stress, produced symptoms (headaches, dizziness, sweating).  
x BP improved (and treatment was not needed) when symptoms abated or stress reduced  
Participants disliked treatment and its side effects and feared addiction. They commonly 
reduced/stopped treatment without consulting their doctor.  
External factors preventing adherence included no time to take drugs or see HCP; no health 
insurance, unable to afford clinical care, cost of healthy food; forgetfulness 
Schlomann 2007 26 
11 studies 
R-AMSTAR = 22 
To explore lay beliefs about BP and 
its treatment in order to develop a 
foundation for better partnership 
with patients.  
People with hypertension in the US 
 
HCPs and patients’ have incongruent beliefs about BP regarding the presence of symptoms, 
and the need to take medications for the rest of one’s life.  Many patients, especially African 
Americans, distrust providers impeding effective treatment. Improved professional–patient 
partnerships, considering discrepancies in beliefs, are necessary to improve BP control. 
Note:  HBPM = Home Blood Pressure Monitoring.  HCPs = healthcare professionals.  LTCs = long term conditions.  LMICs = Low and Middle Income Countries   
Table 1 - summary of included qualitative papers
 1 
Table 2.    Summary of the characteristics and key findings of included quantitative reviews  
Star rating: Review;  
RCTs, Participants,  
R-AMSTAR, Duration,  
Review focus; Target group; 
Setting; Comparator, 
Components of the interventions 
mapped to PRISMS taxonomy[9] 
Methods of analysis: 
Effectiveness on BP (mean diff inmmHg 
(95%CI); adherence 
Comments of authors/ 
reviewers 
*Beratarrechea 2017,27  
4 RCTs, n=1667  
R-AMSTAR = 28 
Duration 6w-12m  
 
The impact of mHealth on 
hypertension in adults in LMICs.  
mHealth interventions included: 
HBPM; feedback (SMS or TCs); 
HCP alerts; information 
Comparator: UC  
A1:  Information about BP 
A5: HBPM (telehealth) 
A6: Reminders (re HBP readings, 
medication, appointments, lifestyle) 
A13: Social support (feedback to carer) 
self-care (A13);  
Narrative synthesis:  
BP:   Of 4 trials only one showed a small reduction 
in SBP but not DBP.  The other interventions had 
no effect.  
Adherence: 1 SR reported adherence: no effect  
The authors do not use the 
term 'self-management 
support' to refer to the 
interventions.  
** Bosch-Capblanch 2007,28 
4 RCTs, n= 382, 
R-AMSTAR = 32 
Duration: 6w- 12m 
Contracts between practitioners 
and patients, potentially in the 
context of multi-component 
intervention 
Comparator: Education 
A1: Education 
A3: Adherence (contracts, calendar packs)  
A5: BP monitoring  
A12:  Relaxation 
Narrative synthesis 
BP:  Of 3 trials, 1 showed reduction in DBP; 2 
reported no between-group difference.  
Adherence:  2 trials: 1 reported fewer discontinued 
treatments in intervention; 1 favoured control 
Authors conclude ‘insufficient 
evidence’ to recommend the 
use of patient contracts  
* Chandak-2015,29  
12 RCTs, n-N/R  
R-AMSTAR = 19 
Duration: 6w – 2y 
IT interventions in adults with 
hypertension. Technologies used: 
telemonitoring; CDSS, video-
consultations; PHR.  
Comparator: UC 
A1: Education for patients and/or HCPs 
A5: Telemonitoring of BP + PHR 
A8: On-line communication with HCP 
A11:  Taught HBPM 
Narrative synthesis. 
BP: 2/9 telemonitoring interventions reduced SBP; 
1/9 reduced DBP. Combined HCP-patient 
interventions reduced SBP and DBP. 
Uses and defines the term 
self-management.  Publication 
bias not reported.  
 
*** Cheema-2014,30  
16 RCT, n=3034   
R-AMSTAR= 36 
Duration: 3-13m  
Community pharmacist 
interventions for adults (53-72y) 
in HICs and Thailand)  
Comparator: UC 
A1: Education on BP and drug treatment 
A6: Advice to improve adherence 
A14: Lifestyle advice 
 
Meta-analysis (11RCTs).  
BP: Pharmacist reduced SBP: -6.1mmHg (-3.8 to -
8.4); & DBP: -2.5mmHg (-1.5 to -3.4) 
Narrative synthesis (7RCT):  
Adherence:  6/7 RCTs reported intervention 
increased adherence: OR 12.1% (4.2% to 34.6%) 
Subgroup analysis:  greater 
effect in patients without CVD. 
Does not use the term self-
management. One positive 
outlier from Thailand. 
Publication bias not reported. 
**  Chodosh  2005,31 
13 RCTs, n=1,557,  
R-AMSTAR = 36 
Duration N/R 
Self-management within chronic 
disease programmes in older 
adults  
Comparator: UC 
A1: Education 
A5: Self-monitoring 
A12: Anxiety management/relaxation 
A14: Lifestyle support/exercise 
Meta-analysis  
Compared to control, the intervention reduced:  
x SBP:  ES - 0.39 (-0.51 to -0.28) [# -5mmHg] 
x DBP:  ES  -0.51 (-0.73 to -0.3) 
Possible publication bias: 
Begg test: p=0.091; Egger 
test: p=0.004 
* Crabtree- 2013,32  
2 RCTs, n=1163,  
R-AMSTAR = 18 
Duration 12-24 mo, 
HBPM as a self-management 
tool for patients with hypertension 
in context of team-based care.  
Comparator: UC 
A1: Education (Nurse TCs)  
A3: Self-adjustment of medication 
A5: HBPM (telemonitoring) 
 
Narrative synthesis:  
BP:  2/2 trial showed a reduction in SBP 
 
Small, low quality review.  
Term self-management used 
Publication bias not reported. 
Table 2 - summary of included quantitative papers
 2 
** Dickinson 2006,33 
6 RCTs, n=413, 
R-AMSTAR = 35 
Duration N/R 
Combined lifestyle interventions 
(e.g. salt restriction, exercise, 
relaxation) 
Comparator: UC  
A12: Relaxation 
A14: exercise, weight loss; salt restriction 
 
Meta-analysis  
BP:  Compared to controls, combined lifestyle 
intervention reduced:  
x SBP: -5.5 mmHg (95% CI -8.8 to -2.3) 
x DBP: -4.5 mmHg (95% CI -6.9 to -2.0) 
Individual components (diet, 
exercise, alcohol restriction, 
sodium restriction, and fish oil 
supplements) reduced BP by 
between 2– 6 mmHg  
*** Duan-2017,34 
46 RCTs n= 13,875,  
R-AMSTAR =36 
Duration: 3-24m 
HBPM via telehealth in adults with 
BP and no comorbidities, mean 
age 61.2 yrs; primary care, 
community, outpatient (HICs)., 
Comparator: UC, or HBPM 
without telehealth 
A1: Education  
A3:  Medication management 
A5: Monitoring (telehealth) with feedback 
A6:  Adherence contracts  
A8:   Counselling/telehealth support 
A14: Behavioural management  
Meta-analysis. 
BP: Compared with UC, HBPM: 
x reduced SBP: -3.99 mmHg (-5.06 to –2.93) 
x reduced DBP: -1.99 mmHg (− 2.60 to −1.39) 
x increased %normal BP: RR: 1.16 (1.08–1.25) 
 
HBPM is more effective if 
supported by interactive 
communication with HCP 
Term self-management not 
used. No publication bias 
detected.  
**  Ebrahim 1998,35 
46 RCTs, n>32,000 
R-AMSTAR = 28 
Duration: 2m-5y 
Multi-component (HBPM, 
reminders, regular reviews, 
education) and mono-component 
interventions: 
Comparator: UC 
A1: Education 
A5: HBPM  
A6:  Medication reminders  
Meta-analysis: 
BP: Compared to controls, multi-component self-
management interventions reduced: 
x SBP –7.6 mmHg (–8.5 to -6.7) 
x DBP –4.2mmHg  (-4.6 to  –3.8)) 
Narrative analysis: 
Adherence: Compared to controls, 4/19 multi-
component interventions improved adherence.   
Effective interventions were 
multi component and included 
self-monitoring, and increased 
professional reviews.  Sub-
groups: Education alone had 
no effect on SBP or DBP; 
HBPM alone had a small 
effect on DBP: –1.5mmHg (–
0.3 to –2.7) 
*** Glynn 2010,36 
72 RCTs. n>87,000  
R-AMSTAR = 35 
Duration: 8w-6m 
Multi-component interventions 
including HBPM, or education 
only 
Comparator: UC 
 
A1: Education 
A5: HBPM 
A6: Appointment reminder systems 
Meta-analysis  
BP: Compared to controls, HBPM reduced: 
x SBP: -2.5 mmHg  (-3.7 to -1.3) (n=12) 
x DBP: -1.8 mmHg (-2.4 to -1.2) (n=14) 
Education alone had no effect on SBP: -0.57 (-1.22 
to 0.08); increased DBP: 0.46 (0.07 to 0.86) (n=13) 
Education alone is unlikely to 
produce clinically important 
reductions in BP; HBPM 
require further development 
and evaluation.  Publication 
bias not reported  
** Gwadry-Sridhar 2013,37 
58 RCTs, n=N/R  
R-AMSTAR= 30  
Duration=2d-14y 
Interventions to improve 
medication adherence in adults 
prescribed antihypertensive 
medications  
Comparator: UC 
A1: Education (individual/group; 
IT/audio/video-based; handouts)  
A4: Review (TC/clinic/home) 
A5: HBPM (telemonitoring) 
A6: Adherence (reminders, packaging) 
Narrative synthesis:  
BP: 18/24 RCTs showed significant reduction in 
SBP and/or DBP 
Adherence:  26/34 RCTs showed significant 
improvement in medication adherence 
No data from the multiple sub-
groups of individual 
components. Term self-
management not used. 
Publication bias not reported.   
**Lee 2012,38 
3 RCTs, n=780,  
R-AMSTAR= 33 
Duration: 12 m, 
Strategies (specifically tailored 
counselling for BP) to improve 
the health outcomes among 
patients low health literacy.  
Comparator: UC 
A1: Tailored information (text, videos) and 
feedback 
A8: Patient-HCP interaction (TC) 
A14: Nutritional education 
 
Narrative synthesis:  
BP: Nutritional education improved BP (n=1)  
Adherence: Tailored counselling had no effect on 
medication adherence. (n=3) 
 
Targeted low self-literacy.  
Pictorial handouts increased 
effect on adherence.  Term 
self-management not used. 
Publication bias not reported 
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*** Lu-2012,39  
94RCTs n=24,667 
R-Amstar = 38 
Duration: unclear 
Community interventions 
in China specifically including self-
management strategies  
Comparator: unclear 
A1: Education/self-management 
A4: Review/monitoring 
A13: Social/family support 
Professional training/organisational change   
Meta-analysis:  
BP:  Compared to controls, interventions reduced 
x SBP -13.73 mmHg (-11.53 to -15.93) 
x DBP - 7.33 mmHg (-5.76 to -8.9) 
x Adequately controlled: OR 4.13 (3.5 to 4.87). 
Authors highlight: poor quality 
of RCTs and high risk of bias; 
poor ‘usual care’; intervention 
increased BP prescribing; 
some publication bias for SBP  
* Mansoor 2013,40 
10 RCTs, n= 2,345,  
R-Amstar = 24 
Duration: 6m-27m 
Multi-professional interventions 
targeting medication adherence 
in adults with CVD: Information 
(n=5), behavioural (n=2) or 
combined (n=3) interventions 
Comparator: UC 
A1: Education/information 
A4; Review/monitoring 
A6: Strategies to improve adherence  
A11: Self-management resources 
A13:  Family support with adherence 
A14: Lifestyle advice 
Narrative synthesis:  
BP:  control improved in 3/4 informational; 2/2 
behavioural; 3/3 combined interventions 
Adherence: improved in 0/4 informational; 2/2 
behavioural; 0/1 combined interventions. 
 
Context of healthcare teams. 
Term self-management not 
used. 
** McLean-2013,41   
8 RCTs, n=1,259,  
R-AMSTAR=32 
Duration: 6-24m 
Digital Interventions to support 
patient self-management of 
hypertension: (Mobile, internet, e-
mail, interactive telephone system) 
 Comparator: UC 
A1: Education 
A2: Information on community resources 
A5: HBPM with feedback 
A11: Behavioural skills training 
A14: Tips for lifestyle change,  
Meta-analysis.  
BP: Compared to controls, interventions reduced  
x SBP: -3.74mmHg (-2.19 to -5.58) 
x DBP: -2.37 mmHg (-0.4 to -4.35) 
 
HBPM increased effect on 
DBP: -4.02 mmHg (-2.93 to -
5.12). Term self-management 
used and defined.  No 
publication bias. 
* Ogedegbe 2006,42 
11 RCTs, n=1,550 
R-AMSTAR = 27 
Duration: 8w-2y 
HBPM within multi-component 
interventions to improve 
adherence.   
Comparator: UC 
A1: Education 
A4: Regular reviews 
A5: HBPT 
A6: Reminders, adherence counselling  
A8: Patient-HCP interaction (TC)  
Narrative synthesis  
BP:  7/11 reported improved BP control 
Adherence:  6/11 reported improved adherence.  
HBPM was more effective in 
multi-component 
interventions.   Publication 
bias not reported 
*** Omboni 2013,43  
23 RCTs, n=7,037,  
R-AMSTAR= 37 
Duration: 8w-24y 
HBPM with telemonitoring 
including: telephone, mobile phone 
or, Internet transmission  
Comparator: UC.  
A1: Education 
A4: Regular nurse management 
A5: HBPM + telemonitoring 
A14: Lifestyle behavioural support   
Meta-analysis 
BP: Compared to controls, telemonitoring reduced: 
x SBP -4.72mmHg (-6.18 to -3.24) 
x DBP -2.45 mmHg (-3.33 to -1.57). 
x ABPM SBP -3.48 mmHg (- 5.32 to -1.64) 
x ABPM DBP -1.43 (-2.86 to 0).  
Adherence: No effect on medication adherence 
HBPM groups were 
prescribed more medication.  
Term self-management not 
used. Publication bias not 
reported 
** Proia 2014,44 
52 RCTs, n=N/R  
R-Amstar 31 
Duration: 6-12 m 
Team based interventions for 
improving BP control (GPs, nurses, 
pharmacists, dietitians, social 
workers, CHWs) 
Comparator: UC 
A1: education about BP/medication  
A6: adherence support 
A11: self-management resources  
A14:  lifestyle behaviour change 
 
Narrative synthesis: 
BP:  Compared to controls, the change in mean BP 
in intervention group was greater: 
x SBP: median 5.4 mmHg (IQR.2.0 to 7.2)  
x DBP: median 1.8 mmHg (IQR 0.7 to 3.2 
Teams including a pharmacist 
had greater effect. Self-
management term used but 
not defined. Publication bias 
not reported 
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** Quinones 2014,45 
7 RCTs, n=1,332 
R-AMSTAR 39 
Duration N/R 
Group education (self-
management or didactic) for 
people with LTCs  
Comparator: UC (or didactic 
education) 
A1: Didactic or self-management education  
A11: Practical skills training 
 
 
Narrative synthesis:  
BP:  compared to UC: 3/3 SM education groups 
and 1/3 didactic education group reduced BP  
Didactic education vs SM education (1 study): no 
difference in BP reduction, but more SM education 
patients had BP controlled (70% vs 44%, p=0.04) 
Publication bias assessed, but 
not reported for hypertension.    
 
**Radhakrishnan 2012,46 
1 RCT;  n=634,  
R-Amstar 32 
Duration: 6-12m, 
Tailored interventions on self-
management behaviours in 
patients with LTCs  
 Comparator: UC  
A1: Education  
A4: Nurse/GP reviews (TC) 
A5:  HBPM 
A14: Lifestyle (exercise) counselling 
Narrative synthesis 
BP: compared to UCs, 11% (1.9 to19.8) more 
people using HBPM gained control of BP 
Adherence:  ‘Improvement in self-reported 
medication adherence. 
Only one of the RCTs 
addressed hypertension 
Self-management term used 
and defined. Publication bias 
not reported. 
** Riegel 2016,47  
13 RCT, 2,050,  
R-AMSTAR = 31  
Duration: 2m-39m 
Nutritional interventions given by 
a registered dietitian in a 
multidisciplinary team to reduce BP 
Comparator: UC 
A14:  Nutritional advice (sodium restriction, 
weight loss, fruit and vegetables) 
 
Meta-analysis: 
BP:  Compared to UC, interventions reduced:  
x SBP: -2.82 mmHg (-4.03 to -1.62) 
x DBP: -1.37 mmHg (-2.11 to -0.62)  
Subgroups: Sodium restriction 
calorie restriction were 
effective.   Self-management 
term not used. No significant 
publication bias 
*** Ruppar-2017,48  
37 RCTs, n= 5,228,  
R-AMSTAR=41  
Duration: N/R 
Medication adherence 
Interventions using multiple 
behaviour change strategies; for 
black adults (US, South Africa) 
Comparator: UC 
A1: Education (disease and medication) 
A5: HBPM and medication monitoring 
A6: Reminders and packaging 
A8: Counselling re medication  
A12: Problem solving (adherence) 
A13: Social support 
Meta-analysis:  
Adherence: Compared to control, interventions 
increased adherence. ES: 0.325 (0.195 to 0.454)  
Individual components:  Only medication packaging 
increased effect size ES: 1.02 vs. 0.23, P=0.006; 
 
Term self-management not 
used.  Some publication bias   
among studies with very large 
positive effect sizes.  Findings 
reflect health disparities in US.  
* Saksena 2010,49 
4 RCTs, n=1,319 
R-AMSTAR = 28 
Duration: N/R 
Computer-based education 
(computer or internet-based) 
Comparator: UC  
A1: Education 
A4: Pharmacist support 
Narrative synthesis  
BP (n=1).  Compared to UC, computer based 
education did not improve BP control (p=0.23), but 
pharmacist-supported computer-based education 
improved proportion with BP control (p<0.001)  
Self-management term not 
used. Publication bias not 
assessed 
*** Schroeder 2008,50 
38 RCTs, n=15,519 
R-AMSTAR = 34 
Duration: 2m-60m 
Medication adherence 
Interventions (education only and 
multi-component interventions) 
Comparator: UC 
A1: Educational programme 
A5: HBPM 
A6: Reminders, packaging and regimes  
A8: Computer counselling 
A12: Teaching self-determination 
Narrative synthesis  
BP: Compared to UC, BP improved in 13/58 
interventions 
Adherence: Compared to UC, adherence 
improved in 19/58 interventions 
Sub-groups: Compared to UC, 
adherence improved in 10/24 
motivational strategies; 1/6 
educational;  7/9  simple 
dosage regimes; 8/18 multi-
component interventions. 
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* Takiya 2004,51 
16 RCTs, n=2,446 
R-AMSTAR = 29 
Duration: 1-6m 
Educational +/- behavioural (n=9) 
interventions to improve 
adherence. 
Comparator: UC 
A1: Education 
A6: Reminders, dosage schedule  
 
Meta-analysis  
Adherence: Compared to controls, overall the 
interventions had no effect: 0.12 (0.08 to 0.16) 
Sub-groups: 
Behavioural/combined 
interventions had no effect; 
improved in 1/3 educational; 
No significant publication bias 
** Vargas 2017,52 
6 RCTs, n= 1466 
R-AMSTAR= 32 
Duration: 2m-12m 
SMS interventions (one-way SMS 
and two-way SMS)  
Comparator: UC 
A1: Education (individual/group) 
A4: Review scheduling 
A5: HBPM with GP feedback 
A6: Medication reminders 
A14: weight loss and smoking cessation 
Narrative synthesis:  
BP: Compared to control, SMS interventions: 
x one-way SMS: 2/2 had no effect 
x two way SMS: 3/4 improved BP control 
Substantial heterogeneity 
precluded meta-analysis.  
Self-management term not 
used. Publication bias not 
assessed.  
* Verbek 2011,53 
9 RCTs, n=2,501 
R-AMSTAR = 24 
Duration: 2m-12m 
Telehealth for the management of 
hypertension  
Comparator: UC.  
A1: Education (individual/group) 
A3: Algorithm for adjusting dose 
A4: Review (Clinic, TC, Pharmacist)  
A5: HBPM with feedback (TC, reports) 
A6: Reminders 
A11: Training in telemonitoring 
A14: Lifestyle advice 
Meta-analysis 
BP: Compared to usual care, telecare reduced: 
x SBP: -5.19 (-2.31 to -8.07) 
x DBP: -2.11 (-0.52 to -3.69) 
The effect was greater when treatment was not 
adjusted during the trial  
Some publication bias   
among studies with small 
sample sizes.   
** Viswanthan 2012, 54 
18 RCTs, n=9,691,  
R-AMSTAR=28 
Duration: 6m-24m 
Medication adherence 
Interventions in US (Face to face, 
phone, telehealth, computer mail, 
written material) 
Comparator: UC 
A1: Education (from pharmacist) 
A4: Collaborative/case management 
A6: Blister packs 
A13: Social support 
Narrative synthesis:  
Adherence: Compared to control, adherence was 
improved in 3/3 trials of case management, and 3/3 
pharmacist-delivered education. Low evidence for 
blister packaging, and behavioural support.  No 
benefit from collaborative care. 
US studies only. 
Self-management term not 
used.  Publication bias not 
assessed.  
* Xu 2014,55  
14 RCTs, n=2,469  
R-AMSTAR =30  
Duration: 1m-2y 
Health education interventions in 
China (Individualised /group 
education;  
Comparator: UC 
 A1: Education (Individual/collective) Meta-analysis 
BP: Compared to control, education reduced: 
x SBP: -19.03 to (-23 to -14.8) 
x DBP -10.33 (-13.4 to -7.26) 
All studies from China.  13/14 
were of low quality: details of 
randomisation not reported..  
Effect attenuated over time 
‘Some publication bias’ 
Abbreviations:   HBPM = Home Blood Pressure Monitoring.  SBP = Systolic Blood Pressure.  DBP = Diastolic Blood Pressure.  ABPM = Ambulatory BP Monitoring.  
LTCs = long term conditions.   CVD = cardiovascular disease.  PHR = Personal Health Record.  SM = Self-Management.    
HCPs = healthcare professionals.  GPs = General Practitioners.  CHWs = Community Health Workers. LMIC=Low and Middle Income Country.  HIC = High Income Country.   
IT = Information Technology.  DI=Digital Interventions. TC = Telephone Consultation. CDSS Computerised Decision Support System.  SMS = Short Messaging Service.   
RCT= Randomised Controlled trial.   SR= Systematic Review.  UC = Usual Care    OR = Odds Ratio.  ES = Effect Size.   
d = day; w = week; m = month; y = year. N/R = not recorded.   
 
Table 3.  Lines of Argument synthesis and components of the quantitative interventions mapped to the PRISMS taxonomy 
PRISMS taxonomy  Qualitative review:   
x Lines of Argument synthesis 
Quantitative reviews including 
component in their intervention 
A1. Information about condition 
and /or its management 
x Differences in understanding of hypertension need to be considered and 
addressed when delivering any training and treatment 24  
x It is important to address the uncertainty relating to the management and 
prognosis of hypertension 22-24,26 with clear patient friendly language 
27 reviews included information 
about hypertension and treatment 
(the remaining two focused on 
information about lifestyle change 
33,47) 
A2. Information about available 
resources 
 One review included information 
about community resources 41 
A3. Provision of/agreement on 
specific clinical action plans 
and/or rescue medication 
Although ‘action plans’ were not discussed by name, the need for patients 
to know how to interpret HBPM readings was mentioned 22 
4 reviews mentioned agreement 
on management plans 28,32,34,53 
A4. Regular clinical review x Symptoms are commonly reported and should be acknowledged 21,23,26  
 
9 reviews included regular clinical 
reviews 37,39,40,42,43,46,49,52,53 
A5. Monitoring of condition with 
feedback 
x Interventions like self-monitoring of BP (HBPM) can foster therapeutic 
alliance 22 and promote a more internal locus of control 
18 reviews included HBPM 27-
29,31,32,34-37,41-43,46,48,50,52,53,56 with 
evidence that feedback (e.g. via 
telehealth) improved 
effectiveness 27,29,32,34,37,41,43,52,53,56  
A6. Practical support with 
adherence (medication or 
behavioural) 
x Adherence, particularly to medication, may be affected by factors 
including symptom guided use and fear of dependence rather than 
simply forgetting to take medication 23,24.  It is important to explore and 
address these issues with patients.  
x Cultural differences may be important although this remains unclear. 
Respecting cultural beliefs is considered necessary by some to improve 
adherence 21 whilst others found the principal themes identified were 
remarkably similar across cultural and ethnic groups 24   
15 reviews addressed adherence 
27,34-37,40,42,44,48,50-54,57. with varied 
results.  Targeted interventions 
38,48 and those involving HBPM 57 
maybe be more effective. 
Table 3 - Synthesis mapped to PRISMS taxonomy
A7. Provision of equipment Although equipment was not specifically discussed, HBPM (which would 
require a sphygmomanometer) was considered as important.   
19 interventions provided HBPM 
equipment 27-29,31,32,34-37,41-43,46,48,50, 
52,53,56,57 
A8. Provision of easy access to 
advice or support when needed 
Telehealth was described as a strategy for providing access to support 22 6 interventions explicitly 
enhanced access to support 27,29, 
34,38,42,50 
A9. Training/rehearsal to 
communicate with health care 
professionals 
x Clinicians need to address the underlying concerns of patients and work 
within the patient’s understanding of hypertension rather than 
‘correcting’ their knowledge to a biomedical model 24,26  Patients may 
have different interpretations regarding the causes of hypertension 
21,24,25 and this should be considered. 
x Mismatch in understanding and management, between the person with 
hypertension and the healthcare professional, was evident across 
studies 22-26. The importance of the therapeutic alliance and need for 
good interpersonal communication skills is evident. 
 
A10. Training/ rehearsal for 
everyday activities 
  
A11. Training/rehearsal for 
practical self-management 
activities 
x It is important that both patients and clinicians are clear how to interpret 
HBPM readings otherwise this may increase anxiety 22  
6 interventions described training 
in practical self-management 
strategies 29,40,41,44,45,53 
A12. Training/ rehearsal for 
psychological strategies 
 5 interventions described 
psychological support 28,31,33,48,50 
A13. Social support x Social and environmental barriers to treatment adherence, including 
family influences, financial issues, need to be considered when 
managing people with hypertension 22,23  
5 interventions included social 
support 27,39,40,48,54  
A14. Lifestyle advice and 
support 
x Access to exercise equipment/facilities, access to healthy food need to 
be considered when managing people with hypertension22,23 
Lifestyle support was included in 
13 interventions, and was the 
focus of one review 33  
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1a:  Search strategies 
 
MEDLINE 
 
1. exp Self Care/ 
2. exp Communication/ 
3. exp Professional-Family Relations/ 
4. exp Telephone/ 
5. exp Professional-Patient Relations/ 
6. exp Health Education/ 
7. exp "Attitude of Health Personnel"/ 
8. exp Cell Phones/ 
9. exp Patient Education as Topic/ 
10. exp Computers, Handheld/ 
11. exp Self Efficacy/ 
12. exp "Activities of Daily Living"/ 
13. exp Self-Help Devices/ 
14. exp Community Health Services/ 
15. exp Rehabilitation/ 
16. ((Self adj2 (car* or manag* or help or administ* or monitor* or medicat*)) or self-car* or self-manag* 
or self-help or self-administ* or self-monitor* or self-medicat* or selfcar* or selfmanagement or selfhelp 
or selfadminist* or selfmonitor* or selfmedicat*).mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
17. (SM or SMS).mp. [mp=title, abstract, original title, name of substance word, subject heading word, 
keyword heading word, protocol supplementary concept word, rare disease supplementary concept 
word, unique identifier, synonyms] 
18. (Responsib* or Autonom*).mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
19. (Manag* or copes or coping).mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
20. "Disease management".mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
21. "expert patient".mp. [mp=title, abstract, original title, name of substance word, subject heading word, 
keyword heading word, protocol supplementary concept word, rare disease supplementary concept 
word, unique identifier, synonyms] 
22. ((professional or clinician) adj2 development).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol supplementary concept word, 
rare disease supplementary concept word, unique identifier, synonyms] 
23. (Educat* or training or skill* or knowledge).mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
24. (Confidence or self-efficacy).mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
25. ((Access* or provi*) adj3 (information or records or results)).mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, keyword heading word, protocol supplementary 
concept word, rare disease supplementary concept word, unique identifier, synonyms] 
26. (Monitor* or self-monitor* or selfmonitor*).mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
27. ((patient or individual* or person* or client*) adj3 (remind* or feedback)).mp. [mp=title, abstract, 
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original title, name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms] 
28. ((Tele adj2 (health or medicine or care)) or tele-health or tele-medicine or tele-care or telehealth or 
telemedicine or telecare).mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier, synonyms] 
29. ("Short message service" or SMS or "mobile phone" or "text message*").mp. [mp=title, abstract, 
original title, name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms] 
30. ((home or environment* or living or assistive) adj2 (adaptation or modif* or equipment or 
technolog*)).mp. [mp=title, abstract, original title, name of substance word, subject heading word, 
keyword heading word, protocol supplementary concept word, rare disease supplementary concept 
word, unique identifier, synonyms] 
31. "Care plan*".mp. [mp=title, abstract, original title, name of substance word, subject heading word, 
keyword heading word, protocol supplementary concept word, rare disease supplementary concept 
word, unique identifier, synonyms] 
32. "Action plan*".mp. [mp=title, abstract, original title, name of substance word, subject heading word, 
keyword heading word, protocol supplementary concept word, rare disease supplementary concept 
word, unique identifier, synonyms] 
33. (Hypno* adj1 (self or home)).mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
34. ((cognitive or psychological or interpersonal or relaxation or biofeedback) adj3 (therap* or 
intervention* or program*)).mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
35. CBT.mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword 
heading word, protocol supplementary concept word, rare disease supplementary concept word, unique 
identifier, synonyms] 
36. Psychoeducation*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier, synonyms] 
37. ((Peer or patient or emotional or social or psychosocial) adj1 (support or group)).mp. [mp=title, 
abstract, original title, name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms] 
38. (Financial adj1 control).mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
39. "personal health budget*".mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
40. ((Financial or monetary or payment* or discount or service*) adj5 incentiv*).mp. [mp=title, abstract, 
original title, name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms] 
41. ((Reduc* or restrict* or control* or limit* or avoid) adj (alcohol or coffee or caffeine or salt)).mp. 
[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, 
protocol supplementary concept word, rare disease supplementary concept word, unique identifier, 
synonyms] 
42. ((Smok* or nicotine or tobacco) adj3 (cessation or quit*)).mp. [mp=title, abstract, original title, name 
of substance word, subject heading word, keyword heading word, protocol supplementary concept 
word, rare disease supplementary concept word, unique identifier, synonyms] 
43. (Exercise or training or rehabilitati*).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
44. ((Lifestyle or occupational) adj1 (intervention* or modification* or therapy)).mp. [mp=title, abstract, 
original title, name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms] 
45. or/1-44 
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46. Hypertension 
47. Hypertens*.mp. [mp=title, abstract, original title, name of substance word, subject heading word, 
keyword heading word, protocol supplementary concept word, rare disease supplementary concept 
word, unique identifier, synonyms] 
48. (Blood adj1 pressure).mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier, synonyms] 
49. or/46-48 
50. Meta-Analysis/ 
51. Meta-Analysis as Topic/ 
52. "Review Literature as Topic"/ 
53. MEDLINE.mp. [mp=title, abstract, original title, name of substance word, subject heading word, 
keyword heading word, protocol supplementary concept word, rare disease supplementary concept 
word, unique identifier, synonyms] 
54. (systematic review* or meta-analy* or metaanaly* or "research synthesis" or "literature review").mp. 
[mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, 
protocol supplementary concept word, rare disease supplementary concept word, unique identifier, 
synonyms] 
55. (systematic adj3 literature).mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
56. (data adj2 extract*).mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier, synonyms] 
57. ((information or data) adj3 synthesis).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
58. cochrane.mp. [mp=title, abstract, original title, name of substance word, subject heading word, 
keyword heading word, protocol supplementary concept word, rare disease supplementary concept 
word, unique identifier, synonyms] 
59. ((qualitative or narrative or thematic or evidence or realist or interpret* or induct* or refutational or 
framework or systematic or textual) adj2 (approach or review* or synthes* or meta-summary or "meta 
summary" or summary)).mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier, synonyms] 
60. (Meta adj1 (summary or narrative or synthesis or ethnograph* or study or data or interpretation or 
aggregation or needs-assessment or "needs assessment")).mp. [mp=title, abstract, original title, name 
of substance word, subject heading word, keyword heading word, protocol supplementary concept 
word, rare disease supplementary concept word, unique identifier, synonyms] 
61. (meta-summary or meta-narrative or meta-synthesis or meta-ethnograph* or meta-study or meta-
data-analysis or meta-data-synthesis or meta-interpretation or meta-aggregation).mp. [mp=title, 
abstract, original title, name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms] 
62. "reciprocal translational analysis".mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
63. ("lines-of-arg?ment synthesis" or "lines of arg?ment synthesis").mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, keyword heading word, protocol supplementary 
concept word, rare disease supplementary concept word, unique identifier, synonyms] 
64. "LOA synthesis".mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier, synonyms] 
65. "grounded formal theory".mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
66. "grounded theory synthesis".mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
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67. (ecological adj2 (triangulation or sentence or synthesis)).mp. [mp=title, abstract, original title, name 
of substance word, subject heading word, keyword heading word, protocol supplementary concept 
word, rare disease supplementary concept word, unique identifier, synonyms] 
68. Phenomenography.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier, synonyms] 
69. ((mixed or multi* or cross) adj1 (method* or design* or research or strategy) adj2 (synthesis or 
review)).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword 
heading word, protocol supplementary concept word, rare disease supplementary concept word, unique 
identifier, synonyms] 
70. ((mixed-method* or multi-method* or mixed-design or multi-design or multiple-methods or multi-
strategy or cross-design) adj2 (synthesis or review)).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol supplementary concept word, 
rare disease supplementary concept word, unique identifier, synonyms] 
71. (Bayesian adj1 (meta-analysis or "meta analysis")).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol supplementary concept word, 
rare disease supplementary concept word, unique identifier, synonyms] 
72. "case survey".mp. [mp=title, abstract, original title, name of substance word, subject heading word, 
keyword heading word, protocol supplementary concept word, rare disease supplementary concept 
word, unique identifier, synonyms] 
73. "qualitative comparative analysis".mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
74. or/50-73 
75. letter.pt. 
76. comment.pt. 
77. editorial.pt. 
78. or/75-77 
79. 74 not 78 
80. 45 and 49 and 79 
81. 80 and 45 and 49 and 79 
82. limit 81 to (english language and humans and yr="2012 -Current") 
 
 
 
  
 6 
AMED 
 
1. exp Self care/ 
2. exp Education professional/ 
3. exp Education nonprofessional/ 
4. exp Human activities/ 
5. exp Self concept/ 
6. exp Self help groups/ 
7. exp Telemedicine/ 
8. exp Communication/ 
9. exp Rehabilitation/ 
10. exp Professional patient relations/ 
11. exp Professional family relations/ 
12. ((Self adj2 (car* or manag* or help or administrat* or monitor* or medicat*)) or self-car* or self-
manag* or self-help or self-adminisrat* or self-monitor* or self-medicat* or selfcar* or selfmanagement 
or selfhelp or selfadministrat* or selfmonitor* or selfmedicat*).mp. [mp=abstract, heading words, title] 
13. (SM or SMS).mp. [mp=abstract, heading words, title] 
14. (Responsib* or Autonom*).mp. [mp=abstract, heading words, title] 
15. (Manag* or copes or coping).mp. [mp=abstract, heading words, title] 
16. "Disease management".mp. 
17. "expert patient".mp. 
18. ((professional or clinician) adj2 development).mp. [mp=abstract, heading words, title] 
19. (Educat* or training or skill* or knowledge).mp. [mp=abstract, heading words, title] 
20. (Confidence or self-efficacy).mp. [mp=abstract, heading words, title] 
21. ((Access* or provi*) adj3 (information or records or results)).mp. [mp=abstract, heading words, title] 
22. (Monitor* or self-monitor* or selfmonitor*).mp. [mp=abstract, heading words, title] 
23. ((patient or individual* or person* or client*) adj3 (remind* or feedback)).mp. [mp=abstract, heading 
words, title] 
24. ((Tele adj2 (health or medicine or care)) or tele-health or tele-medicine or tele-care or telehealth or 
telemedicine or telecare).mp. [mp=abstract, heading words, title] 
25. ("Short message service" or SMS or "mobile phone" or "text message*").mp. [mp=abstract, heading 
words, title] 
26. ((home or environment* or living or assistive) adj2 (adaptation or modif* or equipment or 
technolog*)).mp. [mp=abstract, heading words, title] 
27. "Care plan*".mp. 
28. "Action plan*".mp. 
29. (Hypno* adj1 (self or home)).mp. [mp=abstract, heading words, title] 
30. ((cognitive or psychological or interpersonal or relaxation or biofeedback) adj3 (therap* or 
intervention* or program*)).mp. [mp=abstract, heading words, title] 
31. CBT.mp. 
32. Psychoeducation*.mp. 
33. ((Peer or patient or emotional or social or psychosocial) adj1 (support or group)).mp. [mp=abstract, 
heading words, title] 
34. "Expert patient".mp. 
35. (Financial adj1 control).mp. [mp=abstract, heading words, title] 
36. "personal health budget*".mp. 
37. ((Financial or monetary or payment* or discount or service*) adj5 incentiv*).mp. [mp=abstract, 
heading words, title] 
38. ((Reduc* or restrict* or control* or limit* or avoid) adj (alcohol or coffee or caffeine or salt)).mp. 
[mp=abstract, heading words, title] 
39. ((Smok* or nicotine or tobacco) adj3 (cessation or quit*)).mp. [mp=abstract, heading words, title] 
40. (Exercise or training or rehabilitati*).mp. [mp=abstract, heading words, title] 
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41. ((Lifestyle or occupational) adj1 (intervention* or modification* or therapy)).mp. [mp=abstract, 
heading words, title] 
42. or/1-41 
43. hypertension/ 
44. Hypertens*.mp. 
45. (Blood adj1 pressure).mp. 
46. or/43-45 
47. meta analysis/ 
48. MEDLINE.mp. 
49. (systematic review* or meta-analy* or metaanaly* or "research synthesis" or "literature review").mp. 
[mp=abstract, heading words, title] 
50. (systematic adj3 literature).mp. [mp=abstract, heading words, title] 
51. (data adj2 extract*).mp. [mp=abstract, heading words, title] 
52. ((information or data) adj3 synthesis).mp. [mp=abstract, heading words, title] 
53. cochrane.mp. 
54. ((qualitative or narrative or thematic or evidence or realist or interpret* or induct* or refutational or 
framework or systematic or textual) adj2 (approach or review* or synthes* or meta-summary or "meta 
summary" or summary)).mp. [mp=abstract, heading words, title] 
55. (Meta adj1 (summary or narrative or synthesis or ethnograph* or study or data or interpretation or 
aggregation or needs-assessment or "needs assessment")).mp. [mp=abstract, heading words, title] 
56. (meta-summary or meta-narrative or meta-synthesis or meta-ethnograph* or meta-study or meta-
data-analysis or meta-data-synthesis or meta-interpretation or meta-aggregation).mp. [mp=abstract, 
heading words, title] 
57. "reciprocal translational analysis".mp. 
58. ("lines-of-arg?ment synthesis" or "lines of arg?ment synthesis").mp. [mp=abstract, heading words, 
title] 
59. "LOA synthesis".mp. 
60. "grounded formal theory".mp. 
61. "grounded theory synthesis".mp. 
62. (ecological adj2 (triangulation or sentence or synthesis)).mp. [mp=abstract, heading words, title] 
63. Phenomenography.mp. 
64. ((mixed or multi* or cross) adj1 (method* or design* or research or strategy) adj2 (synthesis or 
review)).mp. [mp=abstract, heading words, title] 
65. ((mixed-method* or multi-method* or mixed-design or multi-design or multiple-methods or multi-
strategy or cross-design) adj2 (synthesis or review)).mp. [mp=abstract, heading words, title] 
66. (Bayesian adj1 (meta-analysis or "meta analysis")).mp. [mp=abstract, heading words, title] 
67. "case survey".mp. 
68. "qualitative comparative analysis".mp. 
69. or/47-68 
70. Letter.pt. 
71. (Comment or commentary).pt. 
72. editorial.pt. 
73. or/70-72 
74. 69 not 73 
75. 42 and 46 and 74 
76. limit 75 to (english and yr="2012 -Current") 
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EMBASE 
 
1. exp self care/ 
2. exp health education/ 
3. exp patient education/ 
4. exp telehealth/ 
5. exp interpersonal communication/ 
6. exp empowerment/ 
7. exp self concept/ 
8. exp patient participation/ 
9. ((Self adj2 (car* or manag* or help or administ* or monitor* or medicat*)) or self-car* or self-manag* 
or self-help or self-administ* or self-monitor* or self-medicat* or selfcar* or selfmanagement or selfhelp 
or selfadminist* or selfmonitor* or selfmedicat*).mp. [mp=title, abstract, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword, floating subheading 
word] 
10. (SM or SMS).mp. [mp=title, abstract, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
11. (Responsib* or Autonom*).mp. [mp=title, abstract, heading word, drug trade name, original title, 
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
12. (Manag* or copes or coping).mp. [mp=title, abstract, heading word, drug trade name, original title, 
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
13. "Disease management".mp. [mp=title, abstract, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
14. "expert patient".mp. [mp=title, abstract, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
15. ((professional or clinician) adj2 development).mp. [mp=title, abstract, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, keyword, floating 
subheading word] 
16. (Educat* or training or skill* or knowledge).mp. [mp=title, abstract, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword, floating subheading 
word] 
17. (Confidence or self-efficacy).mp. [mp=title, abstract, heading word, drug trade name, original title, 
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
18. ((Access* or provi*) adj3 (information or records or results)).mp. [mp=title, abstract, heading word, 
drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword, 
floating subheading word] 
19. (Monitor* or self-monitor* or selfmonitor*).mp. [mp=title, abstract, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword, floating subheading 
word] 
20. ((patient or individual* or person* or client*) adj3 (remind* or feedback)).mp. [mp=title, abstract, 
heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade 
name, keyword, floating subheading word] 
21. ((Tele adj2 (health or medicine or care)) or tele-health or tele-medicine or tele-care or telehealth or 
telemedicine or telecare).mp. [mp=title, abstract, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
22. ("Short message service" or SMS or "mobile phone" or "text message*").mp. [mp=title, abstract, 
heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade 
name, keyword, floating subheading word] 
23. ((home or environment* or living or assistive) adj2 (adaptation or modif* or equipment or 
technolog*)).mp. [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, 
drug manufacturer, device trade name, keyword, floating subheading word] 
24. "Care plan*".mp. [mp=title, abstract, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
25. "Action plan*".mp. [mp=title, abstract, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
26. (Hypno* adj1 (self or home)).mp. [mp=title, abstract, heading word, drug trade name, original title, 
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device manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
27. ((cognitive or psychological or interpersonal or relaxation or biofeedback) adj3 (therap* or 
intervention* or program*)).mp. [mp=title, abstract, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
28. CBT.mp. [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword, floating subheading word] 
29. Psychoeducation*.mp. [mp=title, abstract, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
30. ((Peer or patient or emotional or social or psychosocial) adj1 (support or group)).mp. [mp=title, 
abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device 
trade name, keyword, floating subheading word] 
31. (Financial adj1 control).mp. [mp=title, abstract, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
32. "personal health budget*".mp. [mp=title, abstract, heading word, drug trade name, original title, 
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
33. ((Financial or monetary or payment* or discount or service*) adj5 incentiv*).mp. [mp=title, abstract, 
heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade 
name, keyword, floating subheading word] 
34. ((Reduc* or restrict* or control* or limit* or avoid) adj (alcohol or coffee or caffeine or salt)).mp. 
[mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword, floating subheading word] 
35. ((Smok* or nicotine or tobacco) adj3 (cessation or quit*)).mp. [mp=title, abstract, heading word, drug 
trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword, floating 
subheading word] 
36. (Exercise or training or rehabilitati*).mp. [mp=title, abstract, heading word, drug trade name, original 
title, device manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
37. ((Lifestyle or occupational) adj1 (intervention* or modification* or therapy)).mp. [mp=title, abstract, 
heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade 
name, keyword, floating subheading word] 
38. or/1-37 
39. hypertension/ 
40. Hypertens*.mp. [mp=title, abstract, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
41. (Blood adj1 pressure).mp. [mp=title, abstract, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
42. or/39-41 
43. "systematic review"/ 
44. meta analysis/ 
45. MEDLINE.mp. 
46. (systematic review* or meta-analy* or metaanaly* or "research synthesis" or "literature review").mp. 
[mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword, floating subheading word] 
47. (systematic adj3 literature).mp. [mp=title, abstract, heading word, drug trade name, original title, 
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
48. (data adj2 extract*).mp. [mp=title, abstract, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
49. ((information or data) adj3 synthesis).mp. [mp=title, abstract, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword, floating subheading 
word] 
50. cochrane.mp. [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, 
drug manufacturer, device trade name, keyword, floating subheading word] 
51. ((qualitative or narrative or thematic or evidence or realist or interpret* or induct* or refutational or 
framework or systematic or textual) adj2 (approach or review* or synthes* or meta-summary or "meta 
summary" or summary)).mp. [mp=title, abstract, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
52. (Meta adj1 (summary or narrative or synthesis or ethnograph* or study or data or interpretation or 
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aggregation or needs-assessment or "needs assessment")).mp. [mp=title, abstract, heading word, drug 
trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword, floating 
subheading word] 
53. (meta-summary or meta-narrative or meta-synthesis or meta-ethnograph* or meta-study or meta-
data-analysis or meta-data-synthesis or meta-interpretation or meta-aggregation).mp. [mp=title, 
abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device 
trade name, keyword, floating subheading word] 
54. "reciprocal translational analysis".mp. [mp=title, abstract, heading word, drug trade name, original 
title, device manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
55. ("lines-of-arg?ment synthesis" or "lines of arg?ment synthesis").mp. [mp=title, abstract, heading 
word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword, floating subheading word] 
56. "LOA synthesis".mp. [mp=title, abstract, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
57. "grounded formal theory".mp. [mp=title, abstract, heading word, drug trade name, original title, 
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
58. "grounded theory synthesis".mp. [mp=title, abstract, heading word, drug trade name, original title, 
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
59. (ecological adj2 (triangulation or sentence or synthesis)).mp. [mp=title, abstract, heading word, drug 
trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword, floating 
subheading word] 
60. Phenomenography.mp. [mp=title, abstract, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
61. ((mixed or multi* or cross) adj1 (method* or design* or research or strategy) adj2 (synthesis or 
review)).mp. [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword, floating subheading word] 
62. ((mixed-method* or multi-method* or mixed-design or multi-design or multiple-methods or multi-
strategy or cross-design) adj2 (synthesis or review)).mp. [mp=title, abstract, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, keyword, floating 
subheading word] 
63. (Bayesian adj1 (meta-analysis or "meta analysis")).mp. [mp=title, abstract, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, keyword, floating 
subheading word] 
64. "case survey".mp. [mp=title, abstract, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
65. "qualitative comparative analysis".mp. [mp=title, abstract, heading word, drug trade name, original 
title, device manufacturer, drug manufacturer, device trade name, keyword, floating subheading word] 
66. or/43-65 
67. letter.pt. 
68. editorial.pt. 
69. or/67-68 
70. 66 not 69 
71. 38 and 42 and 70 
72. limit 71 to (human and english language and yr="2012 -Current") 
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PSYCINFO 
 
1. exp Self-Care Skills/ 
2. exp Self-Management/ 
3. exp Health Behavior/ 
4. exp Self-Efficacy/ 
5. exp Self-Help Techniques/ 
6. exp Coping Behavior/ 
7. exp Behavior Modification/ 
8. exp Self-Monitoring/ 
9. exp Health Knowledge/ 
10. exp Health Education/ 
11. exp TELEMEDICINE/ 
12. exp Client Education/ 
13. ((Self adj2 (car* or manag* or help or administrat* or monitor* or medicat*)) or self-car* or self-
manag* or self-help or self-adminisrat* or self-monitor* or self-medicat* or selfcar* or selfmanagement 
or selfhelp or selfadministrat* or selfmonitor* or selfmedicat*).mp. [mp=title, abstract, heading word, 
table of contents, key concepts, original title, tests & measures] 
14. (SM or SMS).mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, 
tests & measures] 
15. (Responsib* or Autonom*).mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
16. (Manag* or copes or coping).mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
17. "Disease management".mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
18. "expert patient".mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, 
tests & measures] 
19. ((professional or clinician) adj2 development).mp. [mp=title, abstract, heading word, table of 
contents, key concepts, original title, tests & measures] 
20. (Educat* or training or skill* or knowledge).mp. [mp=title, abstract, heading word, table of contents, 
key concepts, original title, tests & measures] 
21. (Confidence or self-efficacy).mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
22. ((Access* or provi*) adj3 (information or records or results)).mp. [mp=title, abstract, heading word, 
table of contents, key concepts, original title, tests & measures] 
23. (Monitor* or self-monitor* or selfmonitor*).mp. [mp=title, abstract, heading word, table of contents, 
key concepts, original title, tests & measures] 
24. ((patient or individual* or person* or client*) adj3 (remind* or feedback)).mp. [mp=title, abstract, 
heading word, table of contents, key concepts, original title, tests & measures] 
25. ((Tele adj2 (health or medicine or care)) or tele-health or tele-medicine or tele-care or telehealth or 
telemedicine or telecare).mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] 
26. ("Short message service" or SMS or "mobile phone" or "text message*").mp. [mp=title, abstract, 
heading word, table of contents, key concepts, original title, tests & measures] 
27. ((home or environment* or living or assistive) adj2 (adaptation or modif* or equipment or 
technolog*)).mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests & 
measures] 
28. "Care plan*".mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, 
tests & measures] 
29. "Action plan*".mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, 
tests & measures] 
30. (Hypno* adj1 (self or home)).mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
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31. ((cognitive or psychological or interpersonal or relaxation or biofeedback) adj3 (therap* or 
intervention* or program*)).mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
32. CBT.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests & 
measures] 
33. Psychoeducation*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] 
34. ((Peer or patient or emotional or social or psychosocial) adj1 (support or group)).mp. [mp=title, 
abstract, heading word, table of contents, key concepts, original title, tests & measures] 
35. (Financial adj1 control).mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
36. "personal health budget*".mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
37. ((Financial or monetary or payment* or discount or service*) adj5 incentiv*).mp. [mp=title, abstract, 
heading word, table of contents, key concepts, original title, tests & measures] 
38. ((Reduc* or restrict* or control* or limit* or avoid) adj (alcohol or coffee or caffeine or salt)).mp. 
[mp=title, abstract, heading word, table of contents, key concepts, original title, tests & measures] 
39. ((Smok* or nicotine or tobacco) adj3 (cessation or quit*)).mp. [mp=title, abstract, heading word, table 
of contents, key concepts, original title, tests & measures] 
40. (Exercise or training or rehabilitati*).mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] 
41. ((Lifestyle or occupational) adj1 (intervention* or modification* or therapy)).mp. [mp=title, abstract, 
heading word, table of contents, key concepts, original title, tests & measures] 
42. or/1-41 
43. HYPERTENSION/ 
44. Hypertens*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests 
& measures] 
45. (Blood adj1 pressure).mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] 
46. Meta Analysis/ 
47. "Literature Review"/ 
48. MEDLINE.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests 
& measures] 
49. (systematic review* or meta-analy* or metaanaly* or "research synthesis" or "literature review").mp. 
[mp=title, abstract, heading word, table of contents, key concepts, original title, tests & measures] 
50. (systematic adj3 literature).mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
51. (systematic adj3 literature).mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
52. ((information or data) adj3 synthesis).mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] 
53. cochrane.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests & 
measures] 
54. ((qualitative or narrative or thematic or evidence or realist or interpret* or induct* or refutational or 
framework or systematic or textual) adj2 (approach or review* or synthes* or meta-summary or "meta 
summary" or summary)).mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] 
55. (Meta adj1 (summary or narrative or synthesis or ethnograph* or study or data or interpretation or 
aggregation or needs-assessment or "needs assessment")).mp. [mp=title, abstract, heading word, table 
of contents, key concepts, original title, tests & measures] 
56. (meta-summary or meta-narrative or meta-synthesis or meta-ethnograph* or meta-study or meta-
data-analysis or meta-data-synthesis or meta-interpretation or meta-aggregation).mp. [mp=title, 
abstract, heading word, table of contents, key concepts, original title, tests & measures] 
57. "reciprocal translational analysis".mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] 
58. ("lines-of-arg?ment synthesis" or "lines of arg?ment synthesis").mp. [mp=title, abstract, heading 
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word, table of contents, key concepts, original title, tests & measures] 
59. "LOA synthesis".mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, 
tests & measures] 
60. "grounded formal theory".mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
61. "grounded theory synthesis".mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
62. (ecological adj2 (triangulation or sentence or synthesis)).mp. [mp=title, abstract, heading word, table 
of contents, key concepts, original title, tests & measures] 
63. Phenomenography.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] 
64. ((mixed or multi* or cross) adj1 (method* or design* or research or strategy) adj2 (synthesis or 
review)).mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests & 
measures] 
65. ((mixed-method* or multi-method* or mixed-design or multi-design or multiple-methods or multi-
strategy or cross-design) adj2 (synthesis or review)).mp. [mp=title, abstract, heading word, table of 
contents, key concepts, original title, tests & measures] 
66. (Bayesian adj1 (meta-analysis or "meta analysis")).mp. [mp=title, abstract, heading word, table of 
contents, key concepts, original title, tests & measures] 
67. "case survey".mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, 
tests & measures] 
68. "qualitative comparative analysis".mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] 
69. 43 or 44 or 45 
70. or/46-68 
71. 42 and 69 and 70 
72. limit 71 to (human and english language and yr="2012 -Current") 
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CINAHL 
 
S129 S73 AND S77 AND S128  
                Limiters - Publication Year: 2012-2017; English Language 
S128 S123 NOT S127   
S127 S124 OR S125 OR S126   
S126 PT Editorial   
S125 PT Commentary   
S124 PT Letter   
S123 S78 OR S79 OR S80 OR S81 OR S82 OR S83 OR S84 OR S85 OR S86 OR S87 OR S88 OR 
S89 OR S90 OR S91 OR S92 OR S93 OR S94 OR S95 OR S96 OR S97 OR S98 OR S99 OR 
S100 OR S101 OR S102 OR S103 OR S104 OR S105 OR S106 OR S107 OR S108 OR S109 
OR S110 OR S111 OR S112 OR S113 OR S114 OR S115 OR S116 OR S117 OR S118 OR 
S119 OR S120 OR S121 OR S122    
S122 TI ( "Bayesian meta-analysis" OR "Bayesian meta analysis" ) OR AB ( "Bayesian meta-analysis" 
OR "Bayesian meta analysis" )    
S121 TI "qualitative comparative analysis" OR AB "qualitative comparative analysis"    
S120 TI "case survey" OR AB "case survey"    
S119 TI Data N2 extract* OR AB Data N2 extract*   
S118 TI "research synthesis" OR AB "research synthesis"    
S117 TI ( "multi-method* synthesis" OR "multi-method* review" ) OR AB ( "multi-method* synthesis" 
OR "multi-method* review" )    
S116 TI ( "mixed-method* synthesis" OR "mixed-method* review" ) OR AB ( "mixed-method* synthesis" 
OR "mixed-method* review" )    
S115 TI ( "multi* method* synthesis" OR "multi* method* review" ) OR AB ( "multi* method* synthesis" 
OR "multi* method* review" )    
S114 TI ( "Mixed method* synthesis" OR "Mixed method* review" ) OR AB ( "Mixed method* synthesis" 
OR "Mixed method* review" )    
S113 TI Phenomenography OR AB Phenomenography    
S112 TI "ecological synthesis" OR AB "ecological synthesis"    
S111 TI "ecological sentence" OR AB "ecological sentence"    
S110 TI "grounded formal theory" OR AB "grounded formal theory"    
S109 TI ( "lines-of-arg?ment synthesis" OR "lines of arg?ment synthesis" ) OR AB ( "lines-of-arg?ment 
synthesis" OR "lines of arg?ment synthesis" )    
S108 TI ( meta-interpretation or "meta interpretation" ) OR AB ( meta-interpretation or "meta 
interpretation" S107 TI ( meta-data-analysis OR "meta data analysis" ) OR AB ( meta-data-analysis 
OR "meta data analysis" )  
S106 TI ( meta-study OR "meta study" ) OR AB ( meta-study OR "meta study" )    
S105 TI ( meta-ethnograph* OR "meta ethnograph*" ) OR AB ( meta-ethnograph* OR "meta 
ethnograph*" ) S104 TI ( meta-synthes* OR "meta synthes*" ) OR AB ( meta-synthes* OR "meta 
synthes*" )    
S103 TI ( meta-narrative OR "meta narrative" ) OR AB ( meta-narrative OR "meta narrative" )  
  
S102 TI "Framework approach" OR AB "Framework approach"    
S101 TI "interpret* review*" OR AB "interpret* review*"    
S100 TI "Evidence synthes*" OR AB "Evidence synthes*"    
S99 TI "Realist synthes*" OR AB "Realist synthes*"    
S98 TI ( meta-summary OR "meta summary" ) OR AB ( meta-summary OR "meta summary" )  
  
S97 TI Narrative N2 summary OR AB Narrative N2 summary    
S96 TI Narrative N22 synthes* OR AB Narrative N22 synthes*    
S95 TI Narrative N2 review* OR AB Narrative N2 review*    
S94 TI Qualitative N2 summary OR AB Qualitative N2 summary    
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S93 TI Qualitative N2 synthes* OR AB Qualitative N2 synthes*    
S92 TI Qualitative N2 review* OR AB Qualitative N2 review*    
S91 TI cochrane OR AB cochrane    
S90 TI Data N3 synthesis OR AB Data N3 synthesis    
S89 TI Information N3 synthesis OR AB Information N3 synthesis   
S88 TI data N2 extract* OR AB data N2 extract*    
S87 TI systematic N3 literature OR AB systematic N3 literature    
S86 TI "literature review" OR AB "literature review"    
S85 TI "research synthesis" OR AB "research synthesis"    
S84 TI metaanaly* OR AB metaanaly*   
S83 TI "meta-analy*" OR AB "meta-analy*"    
S82 TI "systematic review*" OR AB "systematic review*"    
S81 TI MEDLINE OR AB MEDLINE    
S80 (MH "Literature Review")    
S79 (MH "Meta Analysis")    
S78 (MH "Systematic Review")    
S77 S74 OR S75 OR S76    
S76 TI Blood N1 pressure OR AB Blood N1 pressure    
S75 TI Hypertens* OR AB Hypertens*    
S74 (MH "Hypertension")    
S73 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 
OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 
OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 
OR S36 OR S37 OR S38 OR S39 OR S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 
OR S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR S53 OR S54 OR S55 OR S56 OR S57 
OR S58 OR S59 OR S60 OR S61 OR S62 OR S63 OR S64 OR S65 OR S66 OR S67 OR S68 
OR S69 OR S70 OR S71 OR S72    
S72 TI Smok*N3 cessation OR AB Smok*N3 cessation    
S71 TI Restrict* N1 salt OR AB Restrict* N1 salt    
S70 TI Restrict* N1 alcohol OR AB Restrict* N1 alcohol    
S69 TI Lifestyle N1 modification* OR AB Lifestyle N1 modification*    
S68 TI Lifestyle N1 intervention* OR AB Lifestyle N1 intervention*    
S67 TI training OR AB training    
S66 TI rehabilitati* OR AB rehabilitati*    
S65 TI Exercise OR AB Exercise   
S64 TI Monetary N5 incentiv* OR AB Monetary N5 incentiv*    
S63 TI Financial N5 incentiv* OR AB Financial N5 incentiv*    
S62 TI "personal health budget*" OR AB "personal health budget*"    
S61 TI Financial N1 control OR AB Financial N1 control    
S60 TI Patient N3 group OR AB Patient N3 group   
S59 TI Peer N3 support OR AB Peer N3 support   
S58 TI Psychoeducation* OR AB Psychoeducation*   
S57 TI CBT OR AB CBT   
S56 TI Relaxation N3 program* OR AB Relaxation N3 program*   
S55 TI Psychological N3 intervention* OR AB Psychological N3 intervention*   
S54 TI Cognitive N3 therap* OR AU Cognitive N3 therap*   
S53 TI Hypno* N1 self OR AB Hypno* N1 self   
S52 TI "Action plan*" OR AB "Action plan*"   
S51 TI "Care plan*" OR AB "Care plan*"   
S50 TI Assistive N2 technolog* OR AB Assistive N2 technolog*   
S49 TI Home N2 modif* OR AB Home N2 modif*    
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S48 TI Home N2 adaptation OR AB Home N2 adaptation    
S47 TI "text message*" OR AB "text message*"    
S46 TI Tele N2 care OR AB Tele N2 care    
S45 TI Tele N2 medicine OR AB Tele N2 medicine    
S44 TI Tele N2 health OR AB Tele N2 health    
S43 TI Individual* N3 feedback OR AB Individual* N3 feedback    
S42 TI Individual* N3 remind* OR AB Individual* N3 remind*    
S41 TI Patient N3 feedback OR AB Patient N3 feedback    
S40 TI Patient N3 remind* OR AB Patient N3 remind*    
S39 TI Monitor* OR AB Monitor*    
S38 TI Access* N3 results OR AB Access* N3 results    
S37 TI Access* N3 records OR AB Access* N3 records    
S36 TI Access* N3 information OR AB Access* N3 information    
S35 TI Confidence OR AB Confidence    
S34 TI self-efficacy OR AB self-efficacy    
S33 TI training OR AB training    
S32 TI skill* OR AB skill*    
S31 TI knowledge OR AB knowledge    
S30 TI Educat* OR AB Educat*    
S29 TI Clinician N2 development OR AB Clinician N2 development    
S28 TI Professional N2 development OR AB Professional N2 development    
S27 TI "expert patient" OR AB "expert patient"    
S26 TI "Disease management" OR AB "Disease management"    
S25 TI coping OR AB coping    
S24 TI copes OR AB copes    
S23 TI Manag* OR AB Manag*    
S22 TI Responsib* OR AB Responsib*    
S21 TI Autonom* OR AB Autonom*    
S20 TI SMS OR AB SMS    
S19 TI SM OR AB SM    
S18 TI self-manag* OR AB self-manag*    
S17 TI self-car* OR AB self-car*    
S16 TI Self N2 medicat* OR AB Self N2 medicat*    
S15 TI Self N2 monitor* OR AB Self N2 monitor*    
S14 TI Self N2 administrat* OR AB Self N2 administrat*    
S13 TI Self N2 help OR AB Self N2 help    
S12 TI Self N2 manag* OR AB Self N2 manag*    
S11 TI Self N2 car* OR AB Self N2 car*    
S10 (MH "Rehabilitation+")    
S9 (MH "Support Groups+")    
S8 (MH "Assistive Technology Devices+")    
S7 (MH "Communication Skills")    
S6 (MH "Telehealth+")    
S5 (MH "Attitude of Health Personnel+")    
S4 (MH "Health Education+")    
S3 (MH "Patient Education+")    
S2 (MH "Self Concept+")    
S1 (MH "Self Care+") 
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BNI 
 
1. exp SELF CARE/ 
2. exp SELF MEDICATION/ 
3. PATIENTS EDUCATION/ 
4. exp PERSONAL CARE/ 
5. exp SELF HELP GROUPS/ 
6. PATIENTS EMPOWERMENT/ 
7. exp INTERPERSONAL RELATIONS/ 
8. exp TECHNOLOGY IN HEALTH CARE/ 
9. Disabilities, aids AND APPLIANCES/ 
10. TELEMEDICINE/ 
11. (Self ADJ2 (car* OR manag* OR help OR admistrat* OR monitor* OR medicat* OR self-car* OR 
self-manag* OR self-help OR self-administrat* OR self-monitor* OR self-medicat*)).ti,ab 
12. (SM OR SMS).ti,ab 
13. (Responsib* OR Autonom*).ti,ab 
14. (Manag* OR copes OR coping).ti,ab 
15. ("Disease management").ti,ab 
16. ("expert patient").ti,ab 
17. ((professional OR clinician) ADJ2 development).ti,ab 
18. (Educat* OR training OR skill* OR knowledge).ti,ab 
19. (Confidence OR self-efficacy).ti,ab 
20. ((Access* OR provi*) ADJ3 (information OR records OR results)).ti,ab 
21. (Monitor* OR self-monitor* OR selfmonitor*).ti,ab 
22. ((patient OR individual* OR person* OR client*) ADJ3 (remind* OR feedback)).ti,ab 
23. ((Tele ADJ2 (health OR medicine OR care)) OR tele-health OR tele-medicine OR tele-care OR 
telehealth OR telemedicine OR telecare).ti,ab 
24. ("Short message service" OR SMS OR "mobile phone" OR "text message").ti,ab 
25. ((home OR environment* OR living OR assistive) ADJ2 (adaption OR modif* OR equipment OR 
technolog*)).ti,ab 
26. ("Action plan").ti,ab 
27. (Hypno* ADJ1 (self OR home)).ti,ab 
28. ((cognitive OR psychological OR interpersonal OR relaxation OR biofeedback) ADJ3 (therap* 
OR intervention* OR program*)).ti,ab 
29. (CBT).ti,ab 
30. (Psychoeducation*).ti,ab 
31. ((Peer OR patient OR emotional OR social OR psychosocial) ADJ1 (support OR group)).ti,ab 
32. (Financial ADJ1 control).ti,ab 
33. ("personal health budget*").ti,ab 
34. ((Financial OR monetary OR payment* OR discount OR service*) ADJ5 incentiv*).ti,ab 
35. (Exercise OR training OR rehabilitati*).ti,ab 
36. ((Lifestyle OR occupational) ADJ1 (intervention* OR modification* OR therapy)).ti,ab 
37. ((Reduc* OR restrict* OR control* OR limit* OR avoid) ADJ1 (alcohol OR coffee OR caffeine OR 
salt).ti,ab 
38. ((Smok* OR nicotine OR tobacco) ADJ3 (cessation OR quit*)).ti,ab 
39. (1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 
OR 16 OR 17 OR 18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24 OR 25 OR 26 OR 27 OR 28 
OR 29 OR 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 38) 
40. exp BLOOD PRESSURE/ 
41. (Hypertens*).ti,ab 
42. (Blood ADJ1 pressure).ti,ab 
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43. (40 OR 41 OR 42) 
44. (MEDLINE).ti,ab 
45. ("systematic review" OR "meta-analy*" OR metaanaly* OR "research synthesis" OR "literature 
review").ti,ab 
46. (systematic ADJ3 literature).ti,ab 
47. (data ADJ2 extract*).ti,ab 
48. ((information OR data) ADJ3 synthesis).ti,ab 
49. (cochrane).ti,ab 
50. ((qualitative OR narrative OR thematic OR evidence OR realist OR interpret* OR induct* OR 
refutational OR framework OR systematic OR textual) ADJ2 (approach OR review* OR synthes* 
OR meta-summary OR "meta summary" OR summary)).ti,ab 
51. (Meta ADJ1 (summary OR narrative OR synthesis OR ethnograph* OR study OR data OR 
interpretation OR aggregation OR needs-assessment OR "need assessment")).ti,ab 
52. (meta-summary OR meta-narrative OR meta-synthesis OR meta-ethnograph* OR meta-study 
OR meta-data-analysis OR meta-data-synthesis OR meta-interpretation OR meta-
aggregation).ti,ab 
53. ("reciprocal translational analysis").ti,ab 
54. (RTA).ti,ab 
55. ("lines-of-arg?ment synthesis" OR lines of arg?ment synthesis").ti,ab 
56. ("LOA synthesis").ti,ab 
57. ("grounded formal theory").ti,ab 
58. ("grounded theory synthesis").ti,ab 
59. (ecological ADJ2 (triangulation OR sentence OR synthesis)).ti,ab 
60. (Phenomenography).ti,ab 
61. (((mixed OR multi* OR cross) ADJ1 (method* OR design* OR research OR strategy)) ADJ2 
(synthesis OR review)).ti,ab 
62. ((mixed-method* OR multi-method* OR mixed-design OR multi-design OR multiple-methods OR 
multi-strategy OR cross-design) ADJ2 (synthesis OR review)).ti,ab 
63. ("research synthesis").ti,ab 
64. (Data ADJ2 extract*).ti,ab 
65. ((information OR data) ADJ3 synthesis).ti,ab 
66. (Bayesian ADJ1 (meta-analysis OR "meta analysis")).ti,ab 
67. ("case survey").ti,ab 
68. ("qualitative comparative analysis").ti,ab 
69. (44 OR 45 OR 46 OR 47 OR 48 OR 49 OR 50 OR 51 OR 52 OR 53 OR 54 OR 55 OR 56 OR 
57 OR 58 OR 59 OR 60 OR 61 OR 62 OR 63 OR 64 OR 65 OR 66 OR 67 OR 68) 
70. (39 AND 43 AND 69) 
71. 70 [DT 2012-2017] 
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1b: Selection criteria 
 
Exclusion criteria 
Exclusion criteria must be applied in order, so papers are excluded on the first of these criteria that 
applies.  For example, if not a systematic review or about self-management then it is excluded on 4 
rather than 6. 
If the paper is not excluded on any criteria, then it is included into the meta-review. 
Exclude 1 
Exclude if the review is not written in English. 
Exclude 2 
Exclude if the review does not include human participants. 
Exclude 3 
Exclude reviews published before 1993. 
Exclude 4 
Exclude if the review is not a systematic review of the literature. 
Searches at least two sources, one of which must be an electronic database (e.g. Cochrane 
database, MEDLINE, EMBASE, PsycINFO, BNI, CINAHL), the other may be a second electronic 
database, or one of the following: manual searching of one or more journal(s), checking reference 
lists; and consulting with experts. 
Provides reasoning for the inclusion/exclusion of studies. 
Provides some explanation of how they synthesised the data (e.g. systematic data extraction, 
meta-analysis, narrative synthesis meta-ethnography). 
Exclude 5 
Exclude if the review does not focus on or include one or more of the LTCs you are interested in. 
Exclude 6 
Exclude if the focus of the review is not about: 
Quantitative: self-management support interventions, or 
Qualitative: the lived experience of the condition that can be used to inform self-management 
support, the experience of self-management of the condition, or the experience/feedback of self-
management services/provision either as an intervention or in the real-world community. 
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Exclude 7 
Exclude if the systematic review does not attempt to identify: 
Quantitative: RCTs, or 
Qualitative: qualitative primary studies. 
Exclude 8 
Exclude if the review does not: 
Quantitative: measure one of the following outcomes: use of health-care services; health outcomes 
(including biological markers of disease); symptoms; health behaviours; QoL; self-
efficacy/empowerment, or 
Qualitative: if findings cannot be used to inform self-management support. 
Exclude 9 
Exclude if the paper is a published conference abstract, thesis, protocol, book, book chapter or 
summary of other reviews. 
Exclude 10 
Exclude if the paper is a shorter and less detailed version of a review or if there has been an 
updated version of the review published. 
Often authors do one review, publish it as a Cochrane review first and then about 1 year later 
exactly the same thing gets published in a journal article. However, this is in less depth because of 
the restricted word limit for journals. Therefore the journal article version gets excluded on criteria 
10 for being a shorter, less detailed version of a review. 
If there is a Cochrane review that includes a mixture of designs, such as RCTs, controlled clinical 
trials and observational studies, and does not separate them out in the results but there is a journal 
article version of the same thing that only writes up the RCTs, exclude the Cochrane review on 
criteria 11 and keep the journal article version in. 
A review is considered being an updated review if it includes an updated re-search, so, for 
example, if a Cochrane review is done in 2002 and then the same thing is re-searched in 2006, the 
2002 version is excluded under criteria 10. 
Exclude 11 
Exclude if unable to data extract. 
Different study designs: where systematic reviews include a range of study designs these reviews 
will only be included in our meta-review if they report or comment the findings of the 
RCTs/qualitative studies separately, either under separate subheadings, or in separate 
 21 
paragraphs, or in whole sections of text. Where results across the RCT/qualitative design studies 
are not clearly distinguished from those of other study designs in the results or conclusions 
sections – for example necessitating referral to a table to identify the actual study design of 
individual studies or where the findings from studies of different designs are combined or 
interdigitated – these reviews will not be included in the meta-review. 
Different LCTs: where systematic reviews include both the condition of interest and other 
conditions these reviews will only be included in our metareview if they report or comment the 
findings of the RCTs/ qualitative studies on our index conditions separately, either under separate 
subheadings, or in separate paragraphs, or in whole sections of text. Where it is not possible to 
easily extract results for our conditions of interest from those for other conditions – for example 
necessitating referral to a table to identify the underlying condition in a particular study, or where 
the findings from studies on different conditions are combined or interdigitated – these reviews will 
not be included in the meta-review. 
Exclude 12 
Exclude if the review does not report somewhere in the review the list of studies included. If the 
review provides references in the text, and includes the studies in a reference list at the end of 
review, this is fine. 
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1c: Overlap of studies included in the systematic reviews  
 
 
Qualitative reviews overlap table 
 
 Buckley Fletcher Khatib Marshall Morton Schlomann 
Buckley       
Fletcher -      
Khatib 1 -     
Marshall 3 - 5    
Morton - 2 - -   
Schlomann 1 - - 2 -  
 
Quantitative reviews overlap table 
 
 Ref 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 52 53 54 55 
Beratarrechea 2017 26                              
B-Capblanch 2007 27                              
Chandak 2015 28 1                             
Cheema 2014 29                              
Chodosh 2005 30  1                            
Crabtree 2013 31   2                           
Dickinson 2006 32     2                         
Duan 2017 33 1  4                           
Ebrahim- 1998 34  1  1 1   1                      
Glynn 2010 35    2 1   5 24                     
G-Sridhar 2013 36  1  2 1    6 9                    
Lee 2012 37           2                   
Lu 2012 38                              
Mansoor 2013 39           4                   
McLean 2016 40 1  2     3  1                    
Ogedegbe 2006 41  1      1 2 4 3    1               
Omboni 2013 42   2   1  18  4     1 1              
Proia 2014 43   4 2  1  6  5 6   3 1 1 6             
Quinone 2014 44   1      1  1       1            
Radhakrishnan 2012 45   1   1            1            
Riegel 2016 46                              
Ruppar 2017 47    2     2 2 5 1  1    3            
Saksena 2010 48        1         1 1            
Schroeder 2004 49    2    1 16 13 8    1 5 1  1   3        
Takiya 2004 50        1 8 3 5    1 4 1  1   2  14      
Vargas 2017 52        2  1 1      2             
Verbek 2011 53   1   1  8  3     1 1 9 2     1  1 1    
Visanathan 2012 54        2  2 5 2  2 1 2 2 6    2  2 1  1   
Xu 2014 55             5                 
 Ref 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 52 53 54 55 
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Was an appropriate and detailed design provided?  3 4 4 4 4 4 
Was there duplicate study selection and data extraction?  3 4 4 1 2 1 
Was a comprehensive literature search performed? 3 4 4 3 4 4 
Was the status of publication (i.e. grey literature) used as 
 an inclusion criterion? 
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Was a list of studies (included and excluded) provided? 4 1 1 4 2 1 
Were the characteristics of the included studies provided? 2 3 3 3 3 3 
Was the scientific quality of the included studies assessed 
 and documented? 
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Was the scientific quality of the included studies used 
 appropriately in formulating conclusions? 
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Were the methods used to combine the findings of the 
 studies appropriate? 
4 4 1 3 3 4 
Was the conflict of interest stated? 4 1 3 2 2 1 
Total score/40 34 33 33 29 29 22 
Quality Rating High High High Low Low Low 
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26 Beratarrechea 2017 4 4 3 2 3 2 2 2 2 1 3 28 1,667 * 
27 Bosch-  Capblanch 2007 4 4 3 4 4 3 4 1 1 1 3 32 382 ** 
28 Chandak 2015 4 0 3 1 2 3 1 2 1 1 1 19 N/R * 
29 Cheema 2014 4 4 4 1 3 4 4 3 4 2 3 36 3,034 *** 
30 Chodosh 2005 4 4 4 1 3 4 4 2 4 4 2 36 1,557 ** 
31 Crabtree 2013 3 1 3 1 2 3 1 2 1 0 1 18 1,163 * 
32 Dickinson 2006 4 4 3 1 3 4 4 2 4 4 2 35 413 ** 
33 Duan 2017 4 4 4 2 3 0 4 3 4 4 4 36 13,875 *** 
34 Ebrahim 1998 4 4 3 1 4 2 4 2 1 1 2 28 >32,000 ** 
35 Glynn 2010 4 4 4 4 3 3 4 1 4 1 3 35 >87,000 *** 
36 Gwadry-Sridhar 2013 3 4 3 2 1 1 3 3 3 3 4 30 N/R ** 
37 Lee 2012 4 4 3 1 2 4 3 4 4 0 4 33 780 ** 
38 Lu 2012 3 4 4 2 2 3 4 4 4 4 4 38 24,667 *** 
39 Mansoor 2013 4 0 4 1 1 4 0 0 2 4 4 24 2,345 * 
40 McLean 2016 4 0 3 2 2 4 4 2 4 3 4 32 1,259 ** 
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41 Ogedegbe 2006 4 4 3 2 3 3 3 1 1 1 2 27 1,550 * 
42 Omboni 2013 4 4 4 2 2 3 4 4 4 4 2 37 7,037 *** 
43 Proia 2014 3 1 3 2 2 4 4 2 4 3 3 31 N/R ** 
44 Quinones 2014 4 4 3 1 3 4 4 4 4 4 4 39 1,332 ** 
45 Radhakrishnan 2012 3 4 4 1 3 4 3 2 4 1 3 32 634 ** 
46 Riegel 2016 3 4 3 2 1 1 3 3 4 3 4 31 2,050 ** 
47 Ruppar 2017 4 4 4 4 4 4 4 1 4 4 4 41 5,228 *** 
48 Saksena 2010 4 4 4 4 3 3 1 1 1 2 1 28 1,319 * 
49 Schroeder 2004 4 4 4 4 4 2 4 2 1 2 3 34 15,519 *** 
50 Takiya 2004 4 4 4 1 1 3 2 1 4 3 2 29 2,446 * 
52 Vargas 2017 3 4 4 1 3 4 3 2 4 1 3 32 1,446 ** 
53 Verbek 2011 4 1 2 1 3 4 1 1 2 4 1 24 2,501 * 
54 Visanathan 2012 4 4 2 1 3 2 2 2 4 1 3 28 9,691 ** 
55 Xu 2014 4 2 3 1 2 4 4 2 3 3 2 30 2,469 * 
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2a: Table of aims and key findings    Page 2 
   
2b: Quotes to support the metaphors and sub-themes Page 4 
 
2a: Table of the aim and key findings of the included qualitative systematic reviews 
Author, Year,  
BP studies (total) 
R-AMSTAR score 
Review aim Populations studied Brief summary of key findings  
Buckley 2016 21 
8 studies  
(of 22 papers) 
R-AMSTAR = 29 
To identify beliefs about 
hypertension that are prevalent 
among African Americans. 
African American 
participants    
African American (and other ethnicities’) health beliefs concerning hypertension 
may differ from those of HCPs. HCPs should elicit and discuss the patient’s 
perspective. Interventions designed to reconcile these differences may improve 
adherence to prescribed health behaviours and patient outcomes.  
Fletcher 2016 22 
11 studies 
(of 12 papers) 
R-AMSTAR = 29  
To investigate: the motivation for 
patients to start HBPM; how patients 
and clinicians use HBPM to promote 
behaviour change; perceived barriers 
and facilitators to HBPM use by 
patients and clinicians; the 
communication and interaction 
between the two parties. 
Ambulatory patients 
with hypertension or 
the healthcare 
professionals 
managing their care; 
based in primary care, 
outpatient clinics or 
the community 
Whilst patients are often aware of the risks of high BP, they can find BP readings and 
targets confusing. HBPM, often in conjunction with education about hypertension: 
• gives patients a better understanding of their health state, and a proxy for 
symptoms in order to be able to act.  
• empowers patients and facilitates discussion with clinicians.  
HCPs recognise the benefits of: 
• having the more accurate picture of patients’ BP that is provided by HBPM 
• are concerned about how their patients may react to HBPM  
HBPM facilitated the interaction in consultations about hypertension, bridging a 
potential gap in the traditional patient-clinician relationship. Uncertainty could be 
reduced by providing information about how to interpret HBPM, what variation is 
acceptable, adjustment for home-clinic difference, and for patients what they 
should be concerned about and how to act. 
Khatib 2014 23 
16 studies 
(of 25 papers) 
R-AMSTAR = 33 
To systematically review the 
literature on barriers reported by 
patients and HCPs that may impede 
optimal awareness, treatment, or 
follow up of hypertension. 
Patients with or at risk 
of hypertension. HCPs 
(doctors, nurses, 
other), in primary care 
or hospital. 
There was a wide range of barriers facing patients and HCPs pursuing hypertension 
control, indicating the need for targeted multi-faceted interventions. More 
methodologically rigorous studies that encompass the range of barriers and that 
include low- and middle-income countries are required in order to inform policies to 
improve hypertension control. 
Morton 2016 25 
8 studies 
(of 30 papers) 
R-AMSTAR = 34 
To understand the experiences of 
patients and HCPs using self-
management Digital Interventions 
(DIs) for LTCs 
Adults with LTCs and 
HCPs involved in their 
care.  
Patients using self-management DIs perceived closer contact with HCPs, and felt 
better cared for. Monitoring their own health data gave patients a greater self-
awareness of their condition and motivated them to engage in lifestyle behaviours 
to help improve their data. HCPs perceived clinical benefits to self-management DIs, 
but raised some concerns about the burden of monitoring patient data. 
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Marshall 2012 24 
53 studies 
(of 59 papers) 
R-AMSTAR = 33 
To examine lay understandings 
about the causes of hypertension 
and perspectives on medication.  
To investigate how perspectives 
varied among different cultures and 
ethnic groups. 
To explore how understanding and 
experiences of hypertension 
contributes to poor adherence and 
blood pressure control. 
People with 
uncomplicated 
hypertension, 16 
countries (USA, UK, 
Brazil, Sweden, Ghana, 
Canada, New Zealand, 
Denmark, Finland, Iran, 
Israel, Netherlands, 
Korea, Spain, Tanzania 
Thailand) 
Findings were consistent across countries and ethnic group:  
• Participants thought hypertension was principally caused by stress and 
produced symptoms, particularly headaches, dizziness and sweating.  
• Participants widely intentionally reduced or stopped treatment without 
consulting their doctor.  
• Participants commonly perceived that their blood pressure improved when 
symptoms abated or when they were not stressed, and that treatment was not 
needed at these times.  
• Participants disliked treatment and its side effects and feared addiction.  
External factors that prevented adherence included being unable to find time to 
take the drugs or to see the doctor; having insufficient money to pay for treatment; 
the cost of appointments and healthy food; a lack of health insurance; forgetfulness. 
Schlomann 2007 
26 
11 studies 
R-AMSTAR = 22 
To explore lay beliefs about 
hypertension and its treatment in 
order to develop a foundation for 
better partnering with patients.  
US based qualitative 
studies describing 
patients’ perspectives 
about hypertension 
and its treatment. 
Professional and lay beliefs about hypertension are not congruent. Historical 
factors, lack of congruence between belief systems and poor relationships with 
providers lead many patients, especially African Americans, to distrust providers and 
impede the effectiveness of treatment plans.  
The most problematic discrepancies were related to beliefs about: 
• the presence of symptoms,  
• the need to take medications for the rest of one’s life,  
•  race-specific treatment plans.  
The interactions between nurse practitioners and hypertensive patients have not 
been explored. Professional–patient interactions based on partnership models, with 
specific consideration for the above-stated discrepancies in beliefs, are necessary to 
improve hypertension control. 
Note:  DI=Digital Interventions.   HBPM = Home Blood Pressure Monitoring.  HCPs = healthcare professionals.  LTCs = long term conditions.    
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2b: Thematic Analysis of Qualitative Papers 
Metaphor  Sub-theme Journal article/section from journal theme name/page number 
 
Understanding 
Hypertension 
Beliefs about 
definition and 
causes 
Marshall 2012 / Causes of hypertension and the role of stress / p2-3                                                                                                          
The main causes of hypertension reported by participants were stress, food, being overweight, family history, and alcohol. 
Participants widely and strongly connected stress and worries with hypertension: as a cause, an exacerbating factor, and a 
consequence. A participant from a Dutch study seemed to regard worry and blood pressure as synonymous [Beune 2006] 
Schlomann 2006 / Definition, etiology and mechanism / p 360                                                                                                                     
Stress or emotional factors (including racism, interpersonal issues, and financial difficulties) were viewed as a major cause of 
high blood pressure in a number of the studies [Boutain 2001a; Lukoschek 2003; Schoenberg 2002]. 
The relationship between high blood pressure and food, especially pork, was also consistently noted in those studies that 
explored the causes of high blood pressure  
Buckley 2016/Conceptualizations of Hypertension/p3                                                                                                                                   
Two (9%) studies found that participants considered the condition of hypertension different from the condition of elevated 
blood pressure [Wison 2002; Lukoschek 2003]. These included “high-pertension”, a disease resulting from states of intense 
emotion or anxiety that caused blood to rush unexpectedly to the head [Heurtin-Roberts 1992; Schoenberg 1997; Bailey 1988], 
and “high blood”, a chronic condition of “thickened” or “rich” blood due to genetics and diet [Bailey 1998; Lukoschek 2003]. 
Buckley 2016/Causes of Hypertension/p3                                                                                                                                                            
In ten (46%) studies, African American participants reported that diet was the primary cause of hypertension 
Stress was also identified by African American participants in several studies seven studies (32%)  
Genetics as a cause of hypertension were described by participants from six (27%) studies. Poor rest, weather changes, 
smoking, religion, racism, germs, and pollution were also reported causes of hypertension 
Khatib 2014/ Patient reported barriers in qualitative studies, Capability barriers/P6                                                                    
Knowledge of hypertension risk factors varied by study and within study; some participants were aware that a poor diet, high 
salt and fat intake, and lack of physical activity might be a risk factor for HYPERTENSION [Pham 1999], whereas others reported 
less knowledge of such risk factors [Kusuma 2010; Pham 1999]. Smoking and alcohol were reported as risk factors in one study 
only [Machado 2012]. 
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Marshall 2012 / Causes of hypertension and the role of stress / p3                                                                                                               
In seven studies (Canada, Netherlands, Thailand, United States, and United Kingdom) hypertension was seen by some 
participants as a temporary or curable condition that would not require long term treatment 
In five studies (Tanzania, United Kingdom, and United States), some participants perceived hypertension to be a distinct 
condition from high blood pressure. Most participants understood that hypertension caused serious complications, such as 
stroke (18 studies: Brazil, Sweden, South Korea, Thailand, United Kingdom, United States), death (13 studies: Brazil, Canada, 
Denmark, Netherlands, Sweden, United Kingdom, and United States), and heart disease (14 studies: Brazil, Sweden, United 
Kingdom, and United States). 
Schlomann 2006 / Definition, etiology and mechanism / p360                                                                                                       
Hypertension, high blood pressure, thick blood, and high blood were terms used by study participants to label the health 
problem. For some, these words were used interchangeably, but for others, they referred to different diseases.  
Wilson et al. (2002), in a population that included non-hypertensive individuals, found few participants related hypertension to 
pressure in the vessels and none defined it in terms of actual blood pressure readings. Some attributed it to the blood traveling 
too fast to the brain. 
High blood pressure was not viewed as pathological by all. Some of the participants in Lukoschek’s (2003) study considered it 
as a necessary adjustment for African Americans in response to a stressful life. Similarly, Ogedegbe, Harrison, et al. (2004) 
reported that some viewed it as self-regulating and hence believed it did not require medications for treatment. 
Schlomann 2006 / Treatment / p361-362                                                                                                                                                            
For some, hypertension was viewed as a self-regulating process and therefore not pathological. Attitudes included denial of the 
diagnosis and irresponsibility for one’s health. 
Buckley 2016/Conceptualizations of Hypertension/p3                                                                                                                                   
non-biomedical beliefs about hypertension remain common among African Americans, as three (14%) studies have found that 
participants admitted to a poor understanding of hypertension [Fongwa 2008; Boutin-Foster 2007; Russell 2010] and 6 (27 %) 
provided an inaccurate description of hypertension as an acute, but not chronic, condition [Heurtin-Roberts 1992; Wilson 2002; 
Schoenberg 1997; Bailey 1998; Lukoschek 2003; Kronish 2012]. 
Buckley 2016/ Hypertension related complications/p7                                                                                                                                  
Hypertension was either considered not serious or less serious than other diseases by participants from two (9 %) studies.  
Three (14%) studies indicated that participants thought hypertension was serious 
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Khatib 2014/ Intention and determinants of intention strength/P6                                                                                                      
….they denied the diagnosis and viewed it as a reaction to stressful events and not necessarily a chronic disease [Anthony 
2012]. 
Buckley 2016/ Hypertension-Related Complications/p7 
Stroke and heart disease both recognized as potential complications by participants 5 studies or (23%) 
Five studies (23%) reported that participants considered hypertension a potentially fatal disease 
Individual and 
cultural factors 
Buckley 2016/Comparison with other ethnicities/p7 
Discordant health beliefs may be found in all patients, across a wide range of characteristics, as demonstrated by Marshall et 
al.  However, meaningful differences across ethnicities may exist. 
 
Bailey found that African American participants were more likely to attribute hypertension to psychosocial stress and less likely 
to consider age- and hereditary-related factors compared with Caucasian participants. 
 
Khatib 2014/ Patient reported barriers in qualitative studies, Healthcare system barriers /P6 
Acceptability of available care included ……….lack of respect for the poor [Kusuma 2010], and lack of attention to minorities 
[Barnes 2012; Greer 2010]. 
 
Buckley 2016/Conceptualizations of Hypertension/p3                                                                                                                               
When prompted to discuss hypertension, many African American participants from older studies 5 (23%) described two disease 
states [Heurtin-Roberts 1992; Wilson 2002; Schoenberg 1997; Bailey 1998; Lukoschek 2003]. 
Schlomann 2006 / Definition, aetiology and mechanism / p360                                                                                                        
Lukoschek (2003) explored the beliefs of low income, urban hypertensive African Americans about hypertension. He described 
the belief that hypertension and high blood pressure are separate diseases. Hypertension was described as a curable stress 
response that tightens up the blood vessels and increases the heart rate. In contrast, high blood pressure or ‘‘high blood’’ was 
viewed as an incurable physiological problem caused by certain foods, especially fatty ones or pork. These foods could cause 
the blood to be ‘‘thick.’’ 
The ‘‘thick blood’’ theory or tightening of blood vessels was the primary explanation of the underlying mechanism of high 
blood pressure.  
….the Hmong shamans in Helsel et al.’s (2005) study described some difficulty in conceptualizing high blood pressure. Their 
own language did not have a word for it, and the notion of a chronic illness was not part of their culture. The language of Laos, 
the country of origin for the Hmong, does have a word for high blood pressure—it means, ‘‘fat in the blood.’ 
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Khatib 2014/ Intention and determinants of intention strength/P6 
Motivation barriers refer to intention to change and were reported in terms of exercise, where patients described being too 
lazy or too tired to exercise [Ford 2009]. 
 
Breaking habit barriers were mostly reported in terms of adapting to a healthier lifestyle, whereby patients mainly expressed 
difficulty in changing dietary habits [Parker 2012; Peters 2008]. 
 
Khatib 2014/ Patient reported barriers in qualitative studies, Intention and determinants of intention strength/P6 
Lack of motivation was also reported in terms of medication adherence, where patients admitted to not putting enough effort 
or thought to taking their medication as prescribed. 
 
Buckley 2016/Treatment of Hypertension/p3 
Home remedies, defined in this review as any non-medical treatment option, were used by participants from ten studies 
Stress relief and treatments to reduce stress were reported in four studies (18%) 
 
Lifestyle modifications, such as dietary changes and increased levels of exercise, often were used in conjunction with other 
treatments. 
 
Khatib 2014/ Intention and determinants of intention strength/P6                                                                                                      
Beliefs about the consequences of a healthy lifestyle were also discussed [Horwitz 2004], African American patients, for 
example, were reported as considering HYPERTENSION as being inevitable [Wexler 2009], similarly some patients showed a 
fatalistic perspective suggesting that ‘‘it’s all in God’s hands’’ [Peters 2008]. Therefore improving diet or exercising might not 
make any difference. 
Symptoms Buckley 2016/Perceived Hypertension-Related Symptoms/p3 
Nine (41%) studies reported that participants attributed dizziness to hypertension 
Participants from four (18%) studies perceived changes in vision to be hypertension related 
Mood disturbances or panic attack-like symptoms were described by participants in three (14%) studies 
 
Schlomann 2006  / Symptoms / p361 
Participants described a minimum of three and an average of seven different symptoms associated with high blood pressure. In 
all the studies, a headache, which varied from dull to very severe, was identified as one of the most common symptoms and 
was believed to be caused by stress or fatty foods. 
A change in heartbeat, either increased rate or force, was another commonly cited symptom. 
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The participants described a pounding heartbeat as the most serious symptom as it may warn of a heart attack. Not taking 
one’s medication could cause the heart to pound. If taking the medication did not resolve the problem, participants sought 
medical assistance. 
A general feeling of weakness, fatigue, or sluggishness was noted in all the studies as a symptom of high blood pressure, 
although it was not one of the top-rated symptoms. 
A nosebleed was another commonly reported symptom. 
 
Marshall 2012 / Symptoms and their meaning / p3 
Participants commonly (13 countries, 27 studies) reported symptoms that they connected with hypertension, particularly 
headache and dizziness. Participants in 16 of the studies reported that hypertension caused them no symptoms. 
Adherence Marshall 2012 / Causes of hypertension and the role of stress / p2-3                                                                                                      
Most participants reported that stress led directly to increased blood pressure; but leading a stressful life also caused 
difficulties in finding time to take drugs, eat well, and attend clinic appointments. 
Marshall 2012 / Causes of hypertension and the role of stress / p3 
Participants in five studies (South Korea, Sweden, United Kingdom, and United States) described that taking drugs reduced 
anxiety or worries.[Benson 2006; Lee 2008; Lisper 1997; Lukoschek 2003; Morgan 1995] This was often thought to be a direct 
physiological action of drugs [Benson 2006; Lisper 1997; Lukoschek 2003] but in some cases resulted from feeling protected 
from the complications of hypertension. [Lee 2008; Morgan 1995]. However, participants in two studies (Sweden and United 
States) negatively perceived drugs to function as sedatives. 
 
Marshall 2012 / Attitudes to drug taking / p4 
Participants in nine studies (Brazil, Netherlands, Thailand, United Kingdom, and United States) reported taking drugs regularly 
according to the prescription. A belief that drugs were essential is illustrated by a participant in one of the Brazilian studies. A 
participant in one of the US studies described how she planned to ensure she never ran out of tablets. 
 
Buckley 2016/Treatment of Hypertension/p7 
In six (27%) studies, medication use was reported as a treatment options used by African American participants 
 
Khatib 2014/ Intention and determinants of intention strength/P6 
Beliefs about consequences of taking medication were commonly discussed; participants believed that they did not need anti-
hypertensive medication because they have no symptoms [Ogedegbe 2004; Schafheutle 2002] 
 
Patients also expressed fear of ‘‘dependence’’ on anti- HYPERTENSION medications if they continue to take them [Ogedegbe 
2004; Fongwa 2008] and preferred modifying their lifestyle over taking medication [Aroian 2012]. 
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Marshall 2012 / Intentional non-adherence (link between hypertension, stress and symptoms / p4 
Deliberately choosing to avoid or reduce treatment (intentional non-adherence) was a theme recurring in many of the studies. 
People from the Netherlands, the United Kingdom, and the United States (11 studies) reported that symptoms made them 
more likely to take drugs and lack of symptoms less likely to do so. People from Brazil, Denmark, the Netherlands, Thailand, the 
United Kingdom, and the United States (10 studies) reported they took drugs exclusively only when symptoms were present. A 
participant from the Thai study described how he came to restart treatment after a period of feeling well. A participant in the 
Canadian study stopped taking drugs as he preferred instead to control blood pressure by reducing stress. 
 
Marshall 2012 / Intentional non-adherence (dislike of side effects, fear of addiction; alternative medicines) / p4 
People widely reported intentionally missing doses (Canada, Netherlands, Thailand, United Kingdom, and United States) or 
stopping treatment for a time without informing their doctor (Canada, Denmark, Spain, Netherlands, Thailand, United 
Kingdom, and United States). 
Participants from Spain, the United Kingdom, and the United States experimented with stopping treatment to see how they felt 
without it. Participants from Brazil, Canada, Spain, the United Kingdom, and the United States reported that they self-adjusted 
their drug dose, often because of a desire to avoid side effects or a perception that their blood pressure was controlled. A few 
participants in two studies (United Kingdom and United States) omitted treatment when using alcohol or recreational drugs 
owing to fear of a harmful interaction. 
Participants from Canada, Thailand, the United Kingdom, and the United States (in 10 studies) reported a fear of long term 
problems from taking drugs. These were described as a “build up” of drugs in the body or developing a tolerance or addiction 
to the drugs. A participant from a UK study described his reluctance to take drugs. 
 
Marshall 2012 / Non-intentional non-adherence / p4 
Participants described various external factors that limited their ability to adhere to treatment (non-intentional non-
adherence). Participants commonly forgot to take drugs from time to time in studies from Canada, South Korea, Spain, the 
United Kingdom, and the United States (10 studies in total). Participants in eight studies (New Zealand, South Korea, and 
United States) reported that other commitments meant that they were too busy to take drugs or to attend medical 
appointments.  
 
Schlomann 2006 / Treatment / p361-362 
Ogedegbe, 2004 explored the barriers and facilitators of adherence. They developed a taxonomy of barriers, which included 
the following categories: patient-specific medication factors, disease specific, and logistics. Healthcare provider characteristics 
were not a part of the taxonomy. Patient-specific barriers included forgetfulness, beliefs, and attitudes. Beliefs that presented 
as barriers were those about medications (addictive, cause impotence, undesirable in general) and about Hypertension.  
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Medication factors included side effects, treatment durations, inconvenient dosing (frequency, size of pills), and cost. Disease-
specific factors included the absence of symptoms or the already mentioned adjustment of medications in response to 
symptoms. 
 
Buckley 2016/Treatment of Hypertension/p7 
Many participants used medications only when they perceived symptoms of hypertension to be present 
 
Khatib 2014/ Patient reported barriers in qualitative studies, Intention and determinants of intention strength/P6 
Difficulties with making long term medication adherence a habit were also identified. 
Memory or forgetting to take one’s medication appeared to play an important role in medication adherence 
 
Khatib 2014/ Patient reported barriers in qualitative studies, Medication/P6 
Medication related barriers mainly included side effects experienced due to anti-HYPERTENSION medications [34,36–39], as 
well as dosing frequency, taste, and large pill size [Ogedegbe 2004] . 
 
Fletcher 2016/Interpretation, attribution and action/p216                                                                                                                       
HBPM had an impact on whether patients were adherent, whether they initiated or terminated treatment, and to what extent 
they tailored treatment.  
“I think taking my BP regularly really made me show that I did need to take the medication and that was somewhat motivating . 
. . it did show that the medication was important.” Lambert-Kerzener (2010) [patient, trial]. 
Social factors Marshall 2012 / Causes of hypertension and the role of stress / p2-3                                                                                                         
Stress from work, unemployment, finances, and family matters were often mentioned as impediments to blood pressure 
control, both directly and indirectly.  
Khatib 2014/ Patient reported barriers in qualitative studies, Intention and determinants of intention strength/P6 
In terms of utilizing health care serves and screening for hypertension, participants suggested that sessions aimed at increasing 
health awareness should include groups of patients and be social 
 
Khatib 2014/ Patient reported barriers in qualitative studies, Healthcare system barriers /P6 
In terms of utilizing care, patients reported difficulties with transportation [Pham 1999], inappropriate hours for screening 
services that conflict with working hours [Murimi 2010], and difficulties in getting clinic appointments [Ogedegbe 2004], or 
absence of or inaccessible health care facilities [Kusuma 2010; Peters 2008]. Other availability barriers included transportation 
difficulties hindering medication refills [Barnes 2012; Greer 2010], no interpreter services in physician offices [Pham 1999], lack 
of information targeting population subgroups such as African Americans [Wexler 2009], or short duration of physician 
consultations [Kusuma 2010]. 
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Khatib 2014/ Patient reported barriers in qualitative studies, Intention and determinants of intention strength/P6 
Social influence was reported as both a barrier and a facilitator of improved BP control. Lack of social support, mainly from the 
family, affected medication adherence [Kusuma 2010, Ogedegbe 2004] and changing lifestyle. 
 
Studies also reported that having to cook for oneself differently from the rest of the family was perceived as a barrier 
Social pressure was also reported as a barrier to a healthier lifestyle. 
 
Prioritizing one’s health was also reported as a barrier. Participants found it hard to prioritize clinic visits, diet and exercise over 
needs of family members [Parker 2012; Anthony 2012;; Schafheutle 2002; Aroian 2012; Wexler 2009; Greer 2010] and over 
work. 
 
Patients reported that stress and anxiety may affect BP management; such emotions maybe related to lack of money and jobs, 
single parenting, and living in unsafe neighbourhoods 
 
Khatib 2014/ Patient reported barriers in qualitative studies, Healthcare system barriers /P6 
Patients reported lack of facilities, bad weather, and safety issues as barriers to physical exercise. 
 
Barriers to following a healthy diet included absence of nearby stores that sell healthy foods [Fongwa 2008], limited healthy 
food choices when eating out [Parker 2012], 
 
Cost issues also limited the ability to follow a healthy diet [Horowitz 2004; Ford 2009; Wexler 2009] and to exercise [Peters 
2008]. 
 
Khatib 2014/ Patient reported barriers in qualitative studies, Affordability /P6 
Affordability of care barriers included lack of insurance and high costs of treatment [Barnes 2012; Murimi 2010; Aroian 2012] 
resulting in patients seeking care only for acute problems 
 
Marshall 2012 / Non-intentional non-adherence / p4 
Participants from two Brazilian studies and seven of the US studies reported that hypertension care was too expensive: the 
costs of drugs, healthy food, and visiting doctors were all reported as barriers. Participants in three of the US studies reported 
that not having health insurance hindered them from accessing medical care. 
 
Schlomann 2006 / Treatment / p361-362 
Lifestyle changes were often discussed, such as diet. Cost was often discussed as a barrier, or not viewing the benefits as 
sufficient enough to warrant the negative impact on their lives. Exercise was mentioned infrequently, but an aspect of a 
healthy lifestyle or as a way to offset unhealthy foods.  
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Working 
Together  
Patient/clinician 
relationship 
Schlomann 2006 / Symptoms / p361 
A discrepancy between lay and professional views on symptoms was depicted as problematic to all. 
 
Schlomann 2006 / Symptoms / p361 
Like the general literature on high blood pressure, professional beliefs were depicted as ‘‘expert’’ beliefs and ‘‘right,’’ while lay 
beliefs were depicted as inferior and ‘‘wrong.’’ 
 
Buckley 2016/Treatment of Hypertension/p7 
A mistrust of or concerns about medication use was expressed by participants in five (23%) studies and often was indicted as 
the cause of medication non-adherence or avoidance. 
 
Fletcher 2016/Interpretation, attribution and action/p215 
After using HBPM, patients questioned whether the usual practice of casual clinic measurement was sufficient to provide 
accurate information. “Why we need the machine in the house? [ . . . ] because our visit to the doctor is infrequent.” Abdullah 
(2011) [patient, daily practice] 
 
Fletcher 2016/ patient empowerment, autonomy and self-efficacy, and how HBPM changes the traditional patient-clinician 
dynamic/p216 
Empowering patients also changed the dynamic of the patient-clinician relationship. Some patients thought that clinicians 
could be protective of BP results from the clinic, perhaps because the clinicians did not think the patient could understand. 
“But when we went for a check-up the doctor rarely tells us the actual BP reading. He did not tell us the readings he just said 
it’s ok.” Abdullah (2011) [patient, daily practice] 
 
Fletcher 2016/ patient empowerment, autonomy and self-efficacy, and how HBPM changes the traditional patient-clinician 
dynamic/p217 
Patients also thought that if they were self-monitoring they might be taken more seriously by their clinician. 
 
“It’s certainly given me more meaningful data to speak to the doctor rather than, ‘Well, I think my BP has probably gone up’.” 
Hanley (2013) [patient, trial] 
 
“I think the doctor will observe you’re being a bit more serious than vaguely talking about this, that and the other.” Vasileiou 
(2013) [patient, daily practice] 
 
“ The knowledge and information (i.e. HBPM measurements) they brought to the visit facilitated a bidirectional conversation 
that supported their self-care as well as assisted their physicians ” Lambert-Kerzener (2010) [author interpretation, trial. 
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Whilst most clinicians were generally supportive of their patients self-monitoring, some patients met with apparent disinterest 
from their clinician when they tried to communicate the results of self-monitoring, which was disempowering. The perceived 
disinterest may have been due to a lack of clear guidance for clinicians as to what to do with data from self-monitoring. 
 
“I went back quite soon after the initial diagnosis just to confirm that everything was okay. I mentioned that I’d purchased this 
[HBPM], but that was it really. We didn’t really speak about it anymore than that.” Vasileiou (2013) [patient, daily practice]. 
 
“Well the strength is that I have better control. And then that in collaboration with others [nurse/physician] becomes a good 
foundation for judging how to plan the treatment.” Bengtsson (2014) [patient, intervention development]. 
 
Khatib 2014/ Patient reported barriers in qualitative studies, Capability barriers/P6 
In one study, not knowing about the existence of screening service was reported as a barrier to awareness [35]. 
Skills were discussed in terms of communication between patients and providers, such as not feeling guilty about asking 
questions and knowing what questions to ask [Ogedegbe 2004]. 
 
Khatib 2014/ Patient reported barriers in qualitative studies, Healthcare system barriers /P6 
Acceptability of available care included poor provider-patient communications [36], patients’ distrust in the services provided 
[Wexler 2009; Greer 2010],  
Individualised 
targeted 
treatment 
Fletcher 2016/Interpretation, attribution and action/p215 
There was a belief among some patients that BP targets should be personalised to take their individual circumstances into 
account. 
 
Morton 2016/ Perceiving meaning in self-monitored data/p625 
Understanding self-monitored physiological or symptom readings in the context of lifestyle behaviours such as medication 
adherence or physical activity appeared to give patients across conditions a sense of control over their condition and allowed 
them to assign meaning to their readings, which made the self-monitoring process more worthwhile to maintain over time. 
Perceiving an interaction between lifestyle activities and physio- logical data not only encouraged patients to continue self-
monitoring, but also seemed to motivate them to engage in self-management behaviours in order to see an improvement in 
their readings, for example, to adhere to medication in order to reduce their blood pressure. 
 
Morton 2016/ Patients carefully consider recommended medication changes/p628 
Confidence appeared to be high in …….. some hypertensive patients, As well as feeling confident, patients also needed to 
perceive that a recommended medication change was necessary. For example, hypertensive patients who felt that their 
readings were borderline were less likely to follow advice to change their medication because they didn’t feel their blood 
pressure was high enough to warrant a change. 
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Different 
perspectives 
Schlomann 2006 / Symptoms / p361 
The professional literature describes hypertension as symptomless—a ‘‘silent killer.’’ This is in sharp contrast with the views of 
participants in these studies. While some participants acknowledged that individuals may not have symptoms (or at least not 
always), the consistent finding in these studies is that participants believed that people experience symptoms of high blood 
pressure. 
 
For many participants, the notion of a disease without symptoms did not match paradigms of what a disease is. This raised 
questions about the validity of the diagnosis. To professionals, concern existed that if clients believed there were symptoms 
then they would modify treatments in response to symptoms. The concern is warranted; many participants in these studies did 
just that. 
 
Fletcher 2016/Interpretation, attribution and action/p215 
Patients and clinicians were aware that self-measured blood pressure tended to be lower than clinic measures, which led to a 
dilemma of which measurement was best to use for treatment. Variation between successive HBPM measurements was also 
noted, again with uncertainty as to which readings should be used. 
 
Fletcher 2016/Interpretation, attribution and action/p216 
One article raised the interesting perspective that patients and clinicians may have different expectations of treatment for 
hypertension: “ . . . patients who perceive symptoms they believe are due to high blood pressure should not expect to feel 
better from the treatment. Rather, the treatment should merely serve to prevent these patients from feeling worse.” 
Bengtsson (2014) [author interpretation, intervention development] 
 
Morton 2016/Perceived purpose of DI: who is responsible? /p625 
both patients and HCPs perceive different benefits from the same DIs, 
 
Khatib 2014/ Patient reported barriers in qualitative studies, Capability barriers/P6                                                                           
Gaps in understanding risk factors to and consequences of hypertension were reported [Machado 2012; Kusuma 2010; Pham 
1999; Barnes 2012; Horowitz 2004; Wexler 2009]. 
Importance of 
information 
clarity 
Marshall 2012 / Causes of hypertension and the role of stress / p3 
Awareness of possible complications was often a source of fear. 
 
Fletcher 2016/Interpretation, attribution and action/p213 
How patients interpreted their BP and acted upon self-measurement depended to a large extent on their understanding of high 
BP……….. While patients were aware of some of the potential risks factors for, and consequences of high BP, many did not 
know what their target BP should be. 
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Fletcher 2016/Interpretation, attribution and action/p215 
“ . . . people need to know [target BP] because you do get very uncomfortable whether . . . is this the danger level?” Rickerby 
(2003) [patient, daily practice] 
There was a belief among some patients that BP targets should be personalised to take their individual circumstances into 
account 
 
 “Clearly, participants were trying to find functional ways to define acceptable ranges of BP values. The guideline values were 
and initial broad framework for judgements, but within this, the personalised norm was deployed as a more meaningful rule of 
thumb, especially for those users who had a relatively consistent history of elevated or reduced readings.” Vasileiou (2013) 
[author interpretation, daily practice] 
patients had neither a goal to focus on nor an understanding of the actual blood pressure value.” Bengtsson (2014) [author 
interpretation, intervention development] 
There was a consensus between clinicians and patients that HBPM provided a more accurate picture of BP than casual clinic 
measurement due to the larger number of measurements, and it was this that led some patients to acquire their own monitor. 
“I can’t remember if they . . . if I was advised to go and buy a home monitoring machine, but I decided to do it anyway . . . I 
knew that my blood pressure would be checked every time, regularly at the surgery but certainly twice a year . . . but until that 
I would like more information than that.” Hanley (2013) [patient, intervention development] 
“I could do it one minute and then five minutes later it would be completely different.” Rickerby (2003) [patient, daily practice] 
Patients often found that high BP had little impact on their daily lives due to the lack of symptoms, and that HBPM gave them 
an insight into their condition by acting as a proxy for symptoms. HBPM enabled patients to begin to make associations 
between their BP, symptoms and actions in their daily lives, and were then able to identify ways to self-manage. 
“I mean I remember taking my blood pressure and it reading very high and I thought gosh I feel really great at the moment.” 
Rickerby (2003) [patient, daily practice]  
 
Khatib 2014/ Patient reported barriers in qualitative studies, Capability barriers/P6 
Lack of skills to check blood pressure at home were also discussed [Barnes 2012].  
Patients were not familiar with blood pressure readings and their meaning [Barnes 2012]. 
 
Morton 2016/ Perceiving meaning in self-monitored data/p628 
Those who had stable readings which did not vary over time were less likely to feel a benefit from monitoring and this was the 
case across health conditions [Dinesen 2013; Hallberg 2015; Urowitz 2012], as readings did not then convey any meaning about 
their condition. 
 
Fletcher 2016/Convenience and reassurance vs anxiety and uncertainty/p216 
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Uncertainty for both patients and clinicians stemmed from how to interpret the results of HBPM, in particular coping with 
variability, as well as when and how to act upon the readings. For patients, the main concern was knowing at what point they 
needed to act. 
“Where should it [BP] be? That way I’ll know if me or the missus gotta give a call to an ambulance to come get me . . . because I 
don’t know what it’s supposed to be. I don’t know if I should call.” Schmid (2009) [patient, daily practice] 
 
Khatib 2014/ Patient reported barriers in qualitative studies, Capability barriers/P6 
Patients reported the need for better education regarding HYPERTENSION management and prevention [Pham 1999; Barnes 
2012;Peters 2008]. 
 
Khatib 2014/ Patient reported barriers in qualitative studies, Healthcare system barriers /P6 
lack of guidance and dietary counselling from clinicians [Pham 1999]. 
 
Schlomann 2006 / Treatment / p361-362 
Stress busting was viewed as important, although often people was uncertain how to do this but were willing to learn. 
 
 
Home BP 
monitoring 
Morton 2016/Perceived purpose of DI: who is responsible? /p625 
Patients using self-management DIs generally perceive that they are more aware of their condition, better able to make 
decisions about their own health and engage as an equal with the HCP in meaningful discussions indicating that the DI 
facilitated self-management of their condition. 
 
Morton 2016/ Perceiving meaning in self-monitored data/p625 
This motivation to change behaviour based on physiological data was found even amongst patients using standalone tele-
monitoring systems with no behaviour change support or educational tools, indicating that just having access to the data was 
sufficient to trigger behaviour change. 
 
Fletcher 2016/ patient empowerment, autonomy and self-efficacy, and how HBPM changes the traditional patient-clinician 
dynamic/p216 
Using HBPM increased patients’ involvement in their own care, increased their knowledge about their condition, and 
empowered them to make changes to benefit/improve their BP. 
 
Fletcher 2016/ patient empowerment, autonomy and self-efficacy, and how HBPM changes the traditional patient-clinician 
dynamic/p217 
In contrast HBPM was seen to facilitate discussion, creating a clinician-patient alliance with patients better able to understand 
and be involved in making decisions about treatment.  
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HBPM combined with an increased knowledge of BP and hypertension resulted in patients demonstrating self-efficacy. Rather 
than being in a passive role relying on their GP to both measure their BP and dictate treatment, patients felt more in control of 
their own care. 
 
Fletcher 2016/Interpretation, attribution and action/p215 
There was a consensus between clinicians and patients that HBPM provided a more accurate picture of BP than casual clinic 
measurement due to the larger number of measurements, and it was this that led some patients to acquire their own monitor. 
“I can’t remember if they . . . if I was advised to go and buy a home monitoring machine, but I decided to do it anyway . . . I 
knew that my blood pressure would be checked every time, regularly at the surgery but certainly twice a year . . . but until that 
I would like more information than that.” Hanley (2013) [patient, intervention development] 
“I could do it one minute and then five minutes later it would be completely different.” Rickerby (2003) [patient, daily practice] 
Patients often found that high BP had little impact on their daily lives due to the lack of symptoms, and that HBPM gave them 
an insight into their condition by acting as a proxy for symptoms. HBPM enabled patients to begin to make associations 
between their BP, symptoms and actions in their daily lives, and were then able to identify ways to self-manage. 
“I mean I remember taking my blood pressure and it reading very high and I thought gosh I feel really great at the moment.” 
Rickerby (2003) [patient, daily practice]  
 
Fletcher 2016/Interpretation, attribution and action/p216 
In the absence of symptoms, having HBPM as a symptom proxy helped demonstrate the effectiveness of treatment. 
Patients were able to use HBPM to monitor the effectiveness of their medication and changes to their lifestyle. 
 
Fletcher 2016/Convenience and reassurance vs anxiety and uncertainty/p216 
HBPM was seen to be convenient and easy to use by patients, and the process was in some cases even said to be enjoyable. 
Patients were more relaxed out of the clinic environment and liked the ability to be able to monitor as and when they wanted. 
Patients felt reassured by being able to check symptoms that were potentially attributable to elevated BP. Patients trusted the 
technology of automated BP monitors. 
“And it always comes in handy; you feel a little bit dodgy, you can always take it to see what your blood pressure is.” Ovaisi 
(2011) [patient, trial] 
“I am reassured, and I feel quite happy with the fact that I know that my blood pressure is ok. I don’t have to think ‘oh God I 
haven’t been to the doctor in 4 months, I wonder if my BP is alright’ I know it is.” Jones (2012) [patient, trial]. 
“ . . . it may not be applicable to patients with poor technical skills or those who were easily ‘over focused’.” Halifax (2007) 
[author interpretation, intervention development]. 
Some patients did discuss being anxious, and this was usually in relation to what to do when BP was high. While there is scope 
for patients to become anxious about high BP readings from self-monitoring, it was recognised that this anxiety can either 
inhibit or promote action; anxiety is only a bad thing if patients feel that they are unable to do anything about it. 
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“I would be quite worried if I took it all the time and it was high. I just think that I’m perfectly alright until I go to the surgery in 
four months’ time. I don’t worry about it. I don’t think about it.” Bostock (2009) [patient, intervention development]. 
 
Fletcher 2016/Interpretation, attribution and action/p216 
As well as monitoring BP in relation to medication use, patients were able to use HBPM to attribute lifestyle factors to high BP, 
and then in many cases act in response. However, patients were concerned that they only received generalised advice about 
how lifestyle change could help, and would prefer the information to be tailored to hypertension in particular as well as more 
personalised or tailored advice. 
“When it’s high, then I know it’s either my diet or I’ve not been exercising. So when it’s high I’ll take my walks. I’ll do my 
aerobics and then cut down on meats, go vegetarian.” Abdullah (2011) [patient, daily practice] 
“What I did do, and I’ve stuck to it, I’ve cut out salt. I was overweight a few years ago and I cut out butter, so now I don’t have 
butter and I don’t have salt. I just use general knowledge.” Hanley (2013) [patient, trial] 
“Lifestyle advice was received from multiple sources and perceived to be general rather than being targeted at the reasons for 
them individually developing hypertension.” Hanley (2013) [author interpretation, trial] 
 
Fletcher 2016/Convenience and reassurance vs anxiety and uncertainty/p216 
Little evidence was presented that showed patients feeling burdened by the process of self-monitoring (i.e. according to a 
rigorous protocol), which was a concern of a small number of clinicians.  
Notes: Note:  HBPM = Home Blood Pressure Monitoring.  HCPs = healthcare professionals.  LTCs = long term conditions.   DI=Digital Interventions 
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2016;18:52 
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perspectives: a systematic review and thematic synthesis. Pat Ed Counsel 2016;99:210-9 
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Table 3b.  Focussed data extraction from additional studies identified by forward citation prior to publication (pre-publication check) 
 
Review;  
RCTs, Participants,  
Duration,  
Review focus; Target group; 
Setting; Comparator, 
Components of the interventions 
mapped to PRISMS taxonomy[9] 
Methods of analysis: 
Effectiveness on BP (mean diff mmHg (95%CI); 
adherence 
Comments of authors/ 
reviewers 
Tucker 2017,[56] 
15 RCTs, n=7,138  
Outcome at 12m  
 
Interventions including HBPM in 
adults with a range of support co- 
intervention such as supported 
self-management 
Comparator: no HBPM  
A1:  Information about BP 
A4: Teleconsultations 
A5: HBPM  
A7: Telehealth equipment 
A8:  Personal support throughout trial 
individual patient data meta-analysis:  
BP: Compared to usual care, HBPM with telehealth 
self-management support (n=5RCTs) reduced: 
• SBP: −6.1 (−9.0 to  −3.2) 
• DBP: −2.3 (−4.0 to −0.6) 
HBPM worked best when 
combined with more intensive 
interventions such as 
self-management but had little 
or no effect on its own. 
Morrissey 2013 [57] 
26 RCTs, n= 8,967 
Interventions to improve 
adherence; 10 included HBPM; 13 
included self-management 
strategies 
Comparator: UC 
A1:  Information about BP 
A4: Professional review  
A5: HBPM  
Meta-analysis 
BP:  Compared to adherence support without 
HBPM, use of HBPM was associated with: 
• No effect on SBP: (c2 =0.00; p=0.99) 
• Reduction in DBP: (c2 =5.21; p=0.02) 
Range of adherence 
interventions, half of which 
were clearly self-
management, a quarter were 
not self-management and the 
rest were unclear. 
Abbreviations:   HBPM = Home Blood Pressure Monitoring.  SBP = Systolic Blood Pressure.  DBP = Diastolic Blood Pressure.  
RCT= Randomised Controlled trial.   SR= Systematic Review.  UC = Usual Care     
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3c.  Details of assessments of heterogeneity and publication bias, as reported by the individual 
systematic reviews included in the meta-Forest plot 
 Heterogeneity SBP 
(I2) 
Heterogeneity DBP 
(I2) 
Publication bias 
***Cheema 2014 36% 0% Not reported 
**Dickenson 2006 51% 53% ‘Little evidence of publication bias’ 
***Duan 2017 64% 62% No publication bias 
**Ebrahim 1998 Not reported Not reported 
**Glynn 2010 59% 37% Not reported 
***Lu 2012 97% 97% Smaller studies had smaller effect on SBP 
**McLean 2013 0% 80% No publication bias 
***Omboni 2013 52% 40% No publication bias 
**Riegel 2016 40% 41% Publication bias ‘low’ 
*Verbek 2011 69% - 72% Two small studies may have biased the results 
*Xu 2014 96% 96% Publication bias was ‘small’ 
 
 
 
